<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_9S4KUAj">Text Messaging in Cancer-Supportive Care: A Systematic Review</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">Â© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).</p>
				</availability>
				<date type="published" when="2021-07-15">15 July 2021</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Don</forename><forename type="middle">Thiwanka</forename><surname>Wijeratne</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Medicine , Queen&apos;s University , Kingston , ON K7L 3N6 , Canada;</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Queen&apos;s University</orgName>
								<address>
									<postCode>K7L 3N6</postCode>
									<settlement>Kingston</settlement>
									<region>ON</region>
									<country>Canada;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Meghan</forename><surname>Bowman</surname></persName>
							<idno type="ORCID">0000-0002-1166-4780</idno>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Public Health Sciences , Queen&apos;s University , Kingston , ON K7L 3N6 , Canada;</note>
								<orgName type="department">Department of Public Health Sciences</orgName>
								<orgName type="institution">Queen&apos;s University</orgName>
								<address>
									<postCode>K7L 3N6</postCode>
									<settlement>Kingston</settlement>
									<region>ON</region>
									<country>Canada;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Isobel</forename><surname>Sharpe</surname></persName>
							<email>isobel.sharpe@queensu.ca</email>
							<idno type="ORCID">0000-0002-1166-4780</idno>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Public Health Sciences , Queen&apos;s University , Kingston , ON K7L 3N6 , Canada;</note>
								<orgName type="department">Department of Public Health Sciences</orgName>
								<orgName type="institution">Queen&apos;s University</orgName>
								<address>
									<postCode>K7L 3N6</postCode>
									<settlement>Kingston</settlement>
									<region>ON</region>
									<country>Canada;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Siddhartha</forename><surname>Srivastava</surname></persName>
							<email>srivastava.s@queensu.ca</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Medicine , Queen&apos;s University , Kingston , ON K7L 3N6 , Canada;</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Queen&apos;s University</orgName>
								<address>
									<postCode>K7L 3N6</postCode>
									<settlement>Kingston</settlement>
									<region>ON</region>
									<country>Canada;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Matthew</forename><surname>Jalink</surname></persName>
							<email>matt.jalink@queensu.ca</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Medicine , Queen&apos;s University , Kingston , ON K7L 3N6 , Canada;</note>
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Queen&apos;s University</orgName>
								<address>
									<postCode>K7L 3N6</postCode>
									<settlement>Kingston</settlement>
									<region>ON</region>
									<country>Canada;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bishal</forename><surname>Gyawali</surname></persName>
							<email>gyawali.bishal@queensu.ca</email>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Public Health Sciences , Queen&apos;s University , Kingston , ON K7L 3N6 , Canada;</note>
								<orgName type="department">Department of Public Health Sciences</orgName>
								<orgName type="institution">Queen&apos;s University</orgName>
								<address>
									<postCode>K7L 3N6</postCode>
									<settlement>Kingston</settlement>
									<region>ON</region>
									<country>Canada;</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Department of Oncology , Queen&apos;s University , Kingston , ON K7L 3N6 , Canada</note>
								<orgName type="department">Department of Oncology</orgName>
								<orgName type="institution">Queen&apos;s University</orgName>
								<address>
									<postCode>K7L 3N6</postCode>
									<settlement>Kingston</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_thrvKNa">Text Messaging in Cancer-Supportive Care: A Systematic Review</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2021-07-15">15 July 2021</date>
						</imprint>
					</monogr>
					<idno type="MD5">0B8C8B53746641A107194CF756B8C5E6</idno>
					<idno type="DOI">10.3390/cancers13143542</idno>
					<note type="submission">Received: 11 May 2021 Accepted: 12 July 2021</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T09:29+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_ZXwzTae">cancer</term>
					<term xml:id="_ZHc4EE5">text-based communication</term>
					<term xml:id="_AcRhkmD">text messaging</term>
					<term xml:id="_rNJy7Dw">mHealth</term>
					<term xml:id="_kz7PMYw">supportive care</term>
					<term xml:id="_YFjcYZj">systematic review</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_MCdaMr9"><p xml:id="_uhRFVcN"><s xml:id="_W4vJvNa">Simple Summary: As the number of patients with cancer continues to rise globally, developing methods to support these patients is important for providing high-quality care.</s><s xml:id="_ECx3J4j">The aim of our systematic review is to describe and examine the use of text-based communications in cancer supportive care.</s><s xml:id="_hC234fN">We identified 18 studies suitable for inclusion in our review.</s><s xml:id="_vCXpFnC">Overall, patients were satisfied with using text-based communication in their cancer care.</s><s xml:id="_PN7pRj8">Results were inconsistent within other outcome categories; however, specific interventions yielded some positive results such as the use of reminders for promoting medication adherence.</s><s xml:id="_B3dKGwX">While the results of this review should not be considered conclusive, it illustrates that further research on the use of text-based communications in cancer-supportive care is warranted.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="595.276" lry="841.89"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1." xml:id="_Nv2V5Yc">Introduction</head><p xml:id="_BN9BuUS"><s xml:id="_GH3Ufv4">As the global cancer incidence continues to rise, so has the need for supportive services.</s><s xml:id="_XUtZrZn">Acting as an integral component of cancer care, supportive care aims to provide relief from side effects and aid in care management <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_hA9FXuq">Patients with advanced cancer experience high symptom burden, which is associated with prolonged hospital stays and unplanned hospital readmissions <ref type="bibr" target="#b1">[2]</ref>.</s><s xml:id="_GPZq9EU">Supportive care services for patients with cancer is a substantial healthcare cost <ref type="bibr" target="#b2">[3]</ref>.</s><s xml:id="_VKBzdan">The annual excess economic burden of cancer survivorship ranges from $4427 USD to $16,441 USD per survivor <ref type="bibr" target="#b3">[4]</ref>.</s><s xml:id="_qQk3PpM">Given the considerable clinical and economic burden of caring for those with cancer, it is important to develop cost-effective and efficient supportive care strategies.</s></p><p xml:id="_Qp83z9d"><s xml:id="_eUqgmjd">Digital health interventions facilitate independence and provide reassurance to patients with cancer <ref type="bibr" target="#b4">[5]</ref>.</s><s xml:id="_jgAejCP">Literature suggests that text-based interventions may be a promising alternative or addition to more traditional telehealth methods, such as phone call and internet-based interventions <ref type="bibr" target="#b5">[6]</ref>.</s><s xml:id="_d8Zp7FE">They have been shown to facilitate patient-provider communication, enhance adherence via medication reminders <ref type="bibr" target="#b6">[7]</ref>, educate and motivate patients in the self-management of their care, and simplify patient data collection <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b8">9]</ref>.</s><s xml:id="_V2x3vzK">Specifically, among patients with cancer, text-based communication has been found to improve patient communication and self-management of their care <ref type="bibr" target="#b9">[10]</ref>.</s></p><p xml:id="_EYgUACQ"><s xml:id="_AWXAFk6">Text-based communication can complement other internet-based communication methods <ref type="bibr" target="#b10">[11]</ref>.</s><s xml:id="_QK9WJRj">Employing internet-based communication as a sole method of communication may exacerbate quality of care inequities, as many patients with cancer have limited Internet access <ref type="bibr" target="#b11">[12]</ref>.</s><s xml:id="_NGwqaYd">The World Internet Project, a collaborative research program that studies the impact of digital technology, reported wide disparities in Internet usage based on income levels in almost all countries <ref type="bibr" target="#b12">[13]</ref>.</s></p><p xml:id="_zWMyywP"><s xml:id="_SRs3CT7">The use of text-based communication is a relatively new mode of supporting cancer patients.</s><s xml:id="_CdHPTmQ">While the literature suggests these interventions may be cost-effective and aid in patient-centered care, much of the available evidence is not disease-specific <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15]</ref>.</s><s xml:id="_zTvGmGq">Previous reviews have examined text-based communication as a component of or under the umbrella of digital health or mHealth <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b16">17]</ref>, or have examined text-based communication interventions in patients with chronic disease as a whole <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b18">19]</ref>.</s><s xml:id="_gf3mMEr">Reviews investigating the effects of text-message interventions specifically among patients with cancer are limited, and a full scope of patient-related outcomes has yet to be investigated.</s><s xml:id="_Bh3MCFt">Therefore, we conducted a systematic review aimed at identifying and describing the use of text-based communications to provide supportive care for cancer patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2." xml:id="_djT6WAg">Materials and Methods</head><p xml:id="_PdTGAbZ"><s xml:id="_5QAB5JJ">We conducted a systematic review in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist <ref type="bibr" target="#b19">[20]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1." xml:id="_nrjbb9E">Eligibility Criteria</head><p xml:id="_k2H8CqG"><s xml:id="_FA2Qgee">Our review included primary research studies (clinical trials and observational studies; all study designs) with an available full text and published in the English language.</s><s xml:id="_tztXbMD">Conference abstracts (i.e., no available full text), reviews, case studies, case series, and commentaries/opinions were excluded.</s><s xml:id="_5EbjZQm">Our population of interest was adult patients (age â¥18 years) with diagnosed cancer.</s><s xml:id="_jnkzAJc">Our intervention of interest was use of text-based communication to assist in cancer-supportive care <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_HxKY4KM">Studies that included text-based communication as part of a multi-modal intervention or those requiring internet were not included as we were unable to discern the individual effects of text-based communication.</s><s xml:id="_nQhw8ep">The primary outcome was cancer symptom control.</s><s xml:id="_CyWvYkE">Secondary outcomes included quality of life (defined as a multidimensional phenomenon made up of multiple domains including mental and physical health, physical activity, diet, etc., <ref type="bibr" target="#b20">[21]</ref>), feasibility (e.g., adherence, implementation), patient satisfaction (e.g., patient opinions of the intervention including overall satisfaction, helpfulness, usefulness), and barriers to use.</s><s xml:id="_BNK2ZZ5">Both quantitative and qualitative outcomes were included.</s><s xml:id="_V6QvVcC">Table <ref type="table" target="#tab_4">S1</ref> contains detailed inclusion and exclusion criteria.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2." xml:id="_6MWwqHC">Search Strategy</head><p xml:id="_UVTzdC8"><s xml:id="_5kpwUVP">Electronic searches were performed in MEDLINE, EMBASE, and CINAHL from January 2015 to November 2020.</s><s xml:id="_B3bN5gu">A previous study <ref type="bibr" target="#b21">[22]</ref> surveyed literature up to 2015 on mobile technologies for cancer supportive care.</s><s xml:id="_zHTDQzj">Since the technology and utility of text-based communication has substantially changed in recent years, we chose to evaluate the studies published since 2015 making our results applicable to the current context.</s><s xml:id="_jGxZBhy">Table <ref type="table" target="#tab_5">S2</ref> contains the full search strategy and number of results corresponding to each database.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3." xml:id="_7hHUnGx">Data Extraction and Outcome Measures</head><p xml:id="_ZyhhjTH"><s xml:id="_B679RRp">The Covidence platform <ref type="bibr">[23]</ref> was used to organize and screen all the studies identified by the search.</s><s xml:id="_93TPBf2">Search results from all three databases were aggregated and duplicates were removed.</s><s xml:id="_nKfJ3ze">Two independent reviewers (MB, IS) screened the studies at the title/abstract level for inclusion.</s><s xml:id="_EUXJdpa">The remaining studies were then assessed by the two reviewers for eligibility at the full-text level.</s><s xml:id="_m9dV5fk">Any studies deemed ineligible were excluded based on the following hierarchy: study design, population, exposure/intervention, and outcomes.</s><s xml:id="_Nj4VA2z">Conflicts between the reviewers were resolved through mutual discussion and agreement, or, if no consensus was reached, by a third arbitrator (DTW/BG).</s></p><p xml:id="_dpJF5Y8"><s xml:id="_9ngsZ2d">Upon finalizing the included studies, the two reviewers (MB, IS) extracted relevant information using a predeveloped Microsoft Excel form.</s><s xml:id="_FMKMTaf">Detailed information was collected on the study design, location, population, baseline characteristics, intervention, control, and outcomes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4." xml:id="_tJApcaF">Bias Assessment</head><p xml:id="_wjBw5ah"><s xml:id="_ceYBN7J">Bias assessments were performed on each study by two independent reviewers (MB, IS).</s><s xml:id="_69qwxeK">The Cochrane Risk of Bias Tool <ref type="bibr" target="#b22">[24]</ref>, a 7-item tool that judges biases related to selection, performance, detection, attrition, reporting, and others, was used to assess the randomized trials.</s><s xml:id="_8rnZswN">Each of the 7 items was scored on a 2-point scale, where a score of 2 represents low risk of bias, 1 represents an unclear risk of bias, and 0 represents high risk of bias.</s><s xml:id="_SSNPgSr">The individual item scores were then summed; a total score of 8 or higher was considered low risk of bias and a score below 8 was considered high risk of bias.</s><s xml:id="_EWeZyQN">The Risk Of Bias In Non-randomized Studies-of Interventions (ROBINS-I) tool <ref type="bibr" target="#b23">[25]</ref> was used to assess the non-randomized interventional/observational studies.</s><s xml:id="_rQZFdJ9">This is a 7-item tool that judges biases related to confounding, selection, intervention classification and adherence, missing data, and outcome measurement and reporting.</s><s xml:id="_3SthnCP">Biases corresponding to each of the 7 items were rated as low, moderate, severe, critical, or no information and an overall score was also given.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3." xml:id="_UxRNgp8">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1." xml:id="_beAkRyA">Overview</head><p xml:id="_ZWURH6m"><s xml:id="_jdcDNuw">The electronic database search identified a total of 4449 studies, out of which 18 studies involving 5821 patients were included in the final qualitative synthesis (Figure <ref type="figure" target="#fig_1">1</ref>).</s><s xml:id="_Gxy7gzc">Of the included studies, 9 (50%) were randomized trials <ref type="bibr" target="#b24">[26]</ref><ref type="bibr" target="#b25">[27]</ref><ref type="bibr" target="#b26">[28]</ref><ref type="bibr" target="#b27">[29]</ref><ref type="bibr" target="#b28">[30]</ref><ref type="bibr" target="#b29">[31]</ref><ref type="bibr" target="#b30">[32]</ref><ref type="bibr" target="#b31">[33]</ref><ref type="bibr" target="#b32">[34]</ref> and 9 (50%) were non-randomized interventional/observational studies <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b33">[35]</ref><ref type="bibr" target="#b34">[36]</ref><ref type="bibr" target="#b35">[37]</ref><ref type="bibr" target="#b36">[38]</ref><ref type="bibr" target="#b37">[39]</ref><ref type="bibr" target="#b38">[40]</ref><ref type="bibr" target="#b39">[41]</ref><ref type="bibr" target="#b40">[42]</ref> (Table <ref type="table" target="#tab_0">1</ref>, Table <ref type="table" target="#tab_6">S3</ref>).</s><s xml:id="_jeaFRdH">Sixteen of 18 studies (89%) were conducted in high-income countries (HICs) <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b24">[26]</ref><ref type="bibr" target="#b25">[27]</ref><ref type="bibr" target="#b26">[28]</ref><ref type="bibr" target="#b27">[29]</ref><ref type="bibr" target="#b29">[31]</ref><ref type="bibr" target="#b30">[32]</ref><ref type="bibr" target="#b31">[33]</ref><ref type="bibr" target="#b32">[34]</ref><ref type="bibr" target="#b33">[35]</ref><ref type="bibr" target="#b34">[36]</ref><ref type="bibr" target="#b35">[37]</ref><ref type="bibr" target="#b36">[38]</ref><ref type="bibr" target="#b38">[40]</ref><ref type="bibr" target="#b39">[41]</ref><ref type="bibr" target="#b40">[42]</ref>, the majority (n = 11) in the United States <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b24">26,</ref><ref type="bibr" target="#b26">28,</ref><ref type="bibr" target="#b27">29,</ref><ref type="bibr" target="#b31">[33]</ref><ref type="bibr" target="#b32">[34]</ref><ref type="bibr" target="#b33">[35]</ref><ref type="bibr" target="#b34">[36]</ref><ref type="bibr" target="#b36">38,</ref><ref type="bibr" target="#b38">40,</ref><ref type="bibr" target="#b39">41]</ref>.</s><s xml:id="_aTnbyag">Two studies (11%) were conducted in low-and middle-income countries (LMICs), both in Brazil <ref type="bibr" target="#b28">[30,</ref><ref type="bibr" target="#b37">39]</ref>.</s></p><p xml:id="_QPyN7U6"><s xml:id="_qZMNVAA">Ten studies included patients with any cancer <ref type="bibr" target="#b24">[26,</ref><ref type="bibr" target="#b25">27,</ref><ref type="bibr" target="#b28">30,</ref><ref type="bibr" target="#b30">[32]</ref><ref type="bibr" target="#b31">[33]</ref><ref type="bibr" target="#b32">[34]</ref><ref type="bibr" target="#b34">36,</ref><ref type="bibr" target="#b37">39,</ref><ref type="bibr" target="#b39">41,</ref><ref type="bibr" target="#b40">42]</ref>, while the remaining eight focused on specific cancer types (breast n = 4 <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b27">29,</ref><ref type="bibr" target="#b29">31,</ref><ref type="bibr" target="#b36">38]</ref>, lung n = 2 <ref type="bibr" target="#b33">[35,</ref><ref type="bibr" target="#b35">37]</ref>, endometrial n = 1 <ref type="bibr" target="#b26">[28]</ref>, chronic myeloid leukemia n = 1 <ref type="bibr" target="#b38">[40]</ref>) as seen in Table <ref type="table" target="#tab_0">1</ref>.</s><s xml:id="_NveKKSZ">One study included patients with late-stage cancer only (stage III-IV lung) <ref type="bibr" target="#b33">[35]</ref> and three studies included patients with early stage cancer only <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b27">29,</ref><ref type="bibr" target="#b36">38]</ref>, while the remainder did not use staging as part of their inclusion criteria.</s><s xml:id="_MHM4uxk">Further, 13 studies focused on patients in periods of active treatment <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b27">[29]</ref><ref type="bibr" target="#b28">[30]</ref><ref type="bibr" target="#b29">[31]</ref><ref type="bibr" target="#b30">[32]</ref><ref type="bibr" target="#b31">[33]</ref><ref type="bibr" target="#b32">[34]</ref><ref type="bibr" target="#b34">[36]</ref><ref type="bibr" target="#b35">[37]</ref><ref type="bibr" target="#b36">[38]</ref><ref type="bibr" target="#b37">[39]</ref><ref type="bibr" target="#b38">[40]</ref><ref type="bibr" target="#b39">[41]</ref>, while 4 studies focused on patients during their survivorship phase <ref type="bibr" target="#b24">[26]</ref><ref type="bibr" target="#b25">[27]</ref><ref type="bibr" target="#b26">[28]</ref><ref type="bibr" target="#b40">42</ref>] and 1 did not specify <ref type="bibr" target="#b33">[35]</ref>.</s><s xml:id="_98Ezb62">The total sample sizes at baseline ranged from 14 <ref type="bibr" target="#b37">[39]</ref> to 3429 participants <ref type="bibr" target="#b39">[41]</ref>.</s></p><p xml:id="_SwnSwP8"><s xml:id="_H7QmqZV">Sixteen studies assessed text-based communication interventions used solely for supportive care purposes, such as medication adherence, appointment reminders, weight loss, physical activity motivation, and self-management education <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b24">[26]</ref><ref type="bibr" target="#b25">[27]</ref><ref type="bibr" target="#b26">[28]</ref><ref type="bibr" target="#b27">[29]</ref><ref type="bibr" target="#b28">[30]</ref><ref type="bibr" target="#b29">[31]</ref><ref type="bibr" target="#b30">[32]</ref><ref type="bibr" target="#b31">[33]</ref><ref type="bibr" target="#b32">[34]</ref><ref type="bibr" target="#b33">[35]</ref><ref type="bibr" target="#b34">[36]</ref><ref type="bibr" target="#b37">[39]</ref><ref type="bibr" target="#b38">[40]</ref><ref type="bibr" target="#b39">[41]</ref><ref type="bibr" target="#b40">[42]</ref>.</s><s xml:id="_mxqZRs2">The remaining two studies used text-based communication for supportive care as well as for symptom monitoring (i.e., tracking symptoms experienced by patients) <ref type="bibr" target="#b35">[37,</ref><ref type="bibr" target="#b36">38]</ref>.</s><s xml:id="_ynAQzUp">The most common message frequency was daily (n = 7) <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b28">30,</ref><ref type="bibr" target="#b31">33,</ref><ref type="bibr" target="#b32">34,</ref><ref type="bibr" target="#b36">38,</ref><ref type="bibr" target="#b37">39,</ref><ref type="bibr" target="#b39">41]</ref>, followed by weekly (n = 3) <ref type="bibr" target="#b29">[31,</ref><ref type="bibr" target="#b30">32,</ref><ref type="bibr" target="#b34">36]</ref>, multiple times per week (n = 3) <ref type="bibr" target="#b25">[27,</ref><ref type="bibr" target="#b27">29,</ref><ref type="bibr" target="#b40">42]</ref>, and multiple times per day (n = 3) <ref type="bibr" target="#b26">[28,</ref><ref type="bibr" target="#b33">35,</ref><ref type="bibr" target="#b35">37]</ref>.</s><s xml:id="_sJJEu68">Two studies had no set message frequency <ref type="bibr" target="#b24">[26,</ref><ref type="bibr" target="#b38">40]</ref>.</s><s xml:id="_mJG5yBQ">Text-based communication was initiated by the provider in 16 studies <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b25">[27]</ref><ref type="bibr" target="#b26">[28]</ref><ref type="bibr" target="#b27">[29]</ref><ref type="bibr" target="#b28">[30]</ref><ref type="bibr" target="#b29">[31]</ref><ref type="bibr" target="#b30">[32]</ref><ref type="bibr" target="#b31">[33]</ref><ref type="bibr" target="#b32">[34]</ref><ref type="bibr" target="#b33">[35]</ref><ref type="bibr" target="#b34">[36]</ref><ref type="bibr" target="#b36">[38]</ref><ref type="bibr" target="#b37">[39]</ref><ref type="bibr" target="#b38">[40]</ref><ref type="bibr" target="#b39">[41]</ref><ref type="bibr" target="#b40">[42]</ref> and by the patient in two studies <ref type="bibr" target="#b24">[26,</ref><ref type="bibr" target="#b35">37]</ref>.</s><s xml:id="_Eyxsq5w">Thirty-nine percent (n = 7) of studies sent messages that were personalized to the individual patient <ref type="bibr" target="#b24">[26]</ref><ref type="bibr" target="#b25">[27]</ref><ref type="bibr" target="#b26">[28]</ref><ref type="bibr" target="#b33">35,</ref><ref type="bibr" target="#b35">37,</ref><ref type="bibr" target="#b38">40,</ref><ref type="bibr" target="#b39">41]</ref>, while the remainder used non-personalized messages <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b27">[29]</ref><ref type="bibr" target="#b28">[30]</ref><ref type="bibr" target="#b29">[31]</ref><ref type="bibr" target="#b30">[32]</ref><ref type="bibr" target="#b31">[33]</ref><ref type="bibr" target="#b32">[34]</ref><ref type="bibr" target="#b34">36,</ref><ref type="bibr" target="#b36">38,</ref><ref type="bibr" target="#b37">39,</ref><ref type="bibr" target="#b40">42]</ref>.</s><s xml:id="_4mGZHSV">Eleven studies used unidirectional text-based communication (provider to patient) <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b27">[29]</ref><ref type="bibr" target="#b28">[30]</ref><ref type="bibr" target="#b29">[31]</ref><ref type="bibr" target="#b30">[32]</ref><ref type="bibr" target="#b31">[33]</ref><ref type="bibr" target="#b32">[34]</ref><ref type="bibr" target="#b33">[35]</ref><ref type="bibr" target="#b37">39,</ref><ref type="bibr" target="#b39">41,</ref><ref type="bibr" target="#b40">42]</ref>, six used bidirectional communication (provider to patient and patient to provider) <ref type="bibr" target="#b24">[26]</ref><ref type="bibr" target="#b25">[27]</ref><ref type="bibr" target="#b26">[28]</ref><ref type="bibr" target="#b35">37,</ref><ref type="bibr" target="#b36">38,</ref><ref type="bibr" target="#b38">40]</ref>, and the remainder used text-based communication to initiate an additional form of communication (phone call, mobile app, patient portal, etc.,) <ref type="bibr" target="#b34">[36]</ref>.</s><s xml:id="_rfE74tK">Of the eight studies that reported the language used for text messaging, four <ref type="bibr" target="#b24">[26,</ref><ref type="bibr" target="#b26">28,</ref><ref type="bibr" target="#b31">33,</ref><ref type="bibr" target="#b32">34]</ref> used English, two <ref type="bibr" target="#b28">[30,</ref><ref type="bibr" target="#b37">39]</ref> used Portuguese, one <ref type="bibr" target="#b30">[32]</ref> used French, and one <ref type="bibr" target="#b29">[31]</ref> had the option of either English, Mandarin, or Malay.</s><s xml:id="_QuAFtWY">Study follow-up duration ranged from 1 month <ref type="bibr" target="#b33">[35]</ref><ref type="bibr" target="#b34">[36]</ref><ref type="bibr" target="#b35">[37]</ref><ref type="bibr" target="#b37">39,</ref><ref type="bibr" target="#b40">42]</ref> to 3 years <ref type="bibr" target="#b27">[29]</ref>.</s><s xml:id="_F85PUbS">The following sections discuss study findings within five main outcome categories: patient satisfaction, barriers to use, symptoms, QoL, and feasibility.</s><s xml:id="_pWYdfCK">, Year (Country) Study Design Study Population, Sample Size (I vs. C) Intervention vs.</s><s xml:id="_UzbvGcA">Control Description Follow-Up Randomized Trials Adolescent and All groups received an education booklet and identified 3 survivorship goals.</s><s xml:id="_Wm3nrUF">Text message group: two-way texting system that supported engage-  , Year (Country) Study Design Study Population, Sample Size (I vs. C) Intervention vs.</s><s xml:id="_2sCPwAr">Control Description Follow-Up Randomized Trials Casillas, 2019 (United States) [26] RCT (three-armed, parallel, prospective, single-center) Adolescent and young adult childhood cancer survivors, 28 vs. 25 vs. 25 All groups received an education booklet and identified 3 survivorship goals.</s><s xml:id="_aGvFaqh">Text message group: two-way texting system that supported engagement and provided resources for achieving goals vs. Peer navigation group: telephone calls to discuss goals vs.</s><s xml:id="_p3FeWNa">Control group: encouraged to seek answers to questions regarding educational material 2 mos Gomersall, 2019 (Australia) [27] RCT (two-armed, parallel, prospective, single-center) Cancer patients at least one month post-surgery, 18 vs.</s><s xml:id="_gQf4JV7">18 4 wk exercise rehabilitation program + 12 wk tailored text messages designed to improve whole-of-day activity vs. 4 wk exercise rehabilitation program 3 mos Haggerty, 2017 (United States) [28] RCT (three-armed, parallel, prospective, multi-center) Women with a history of endometrial cancer, BMI 30+, no current or planned treatments, 13 vs. 14 vs. 15 Text message group: 3-5 daily personalized interactive text messages (feedback, support, strategies for behavioral change regarding weight loss) vs. Telemonitoring group: weekly/biweekly telephone counselling vs.</s><s xml:id="_HrCZ5e3">Control group: paper handouts on healthy eating and exercise 6 mos Hershman, 2020 (United States) [29] RCT (two-armed, parallel, prospective, multi-center) Post-menopausal women with breast cancer (stage I-III) taking a third-generation aromatase inhibitor, 348 vs. 354 Twice-weekly educational text messages focusing on barriers to medication adherence vs. no text messaging 3 yrs Rico, 2020 (Brazil) [30] RCT (two-armed, parallel, prospective, single-center) Outpatients undergoing chemotherapy, 59 vs. 59 Daily text messages on prevention of side effects and emotional support, sent automatically in conjunction with cHEmotHErApp vs. standard care 10 mos Spoelstra, 2016 (United States) [34] RCT (two-armed, parallel, prospective, multi-center) Patients newly prescribed OA, 49 vs. 26 Daily medication adherence text messages (based on social cognitive theory, 6 used on a rotating basis) vs. standard care 9 wks Spoelstra, 2015 (United States) [33] RCT (two-armed, parallel, prospective, multi-center) Patients newly prescribed OA, 40 vs. 40 Daily medication adherence text messages (based on social cognitive theory, 6 used on a rotating basis) + weekly symptom management text messages vs. standard care 9 wks Tan, 2020 (Singapore) [31] RCT (two-armed, parallel, prospective, multi-center) Breast cancer patients prescribed AET for at least one year, 123 vs. 121 Weekly text message reminders to take anti-cancer medication vs. standard care 1 yr Villaron, 2018 (France) [32] RCT (two-armed, parallel, prospective, single-center) Outpatients undergoing chemotherapy, 21 vs. 22 Motivational text messages sent at the beginning of each week + physical activity recommendation guide vs. no text messages or recommendation guide Abbreviations: adjuvant endocrine therapy (AET), adverse events (AE), body mass index (BMI), control group (C), hormone receptor positive (HR-positive), intervention group (I), mindfulness-based cognitive therapy (MBCT), month(s) (mos), oral anticancer (OA), randomized controlled trial (RCT), tyrosine kinase inhibitor (TKI), week (wk), year (yr).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2." xml:id="_Sz6NGTk">Risk of Bias</head><p xml:id="_AhKvkWp"><s xml:id="_A7u2nQZ">Seven of the nine randomized trials were classified as low risk of bias (LRB), while the remaining two were high risk of bias (HRB) (Figure <ref type="figure" target="#fig_1">S1</ref>, Table <ref type="table">S4</ref>).</s><s xml:id="_xzzbZAx">Of the nine nonrandomized interventional/observational studies, six reported a serious risk of bias (some important problems exist), two reported not enough information to judge level of bias, and the final study reported moderate risk of bias (sound for a non-randomized study, but not comparable to a well-performed randomized trial) (Figure <ref type="figure">S2</ref>, Table <ref type="table">S5</ref>).</s><s xml:id="_5YdRC5K">Overall, a large portion of the included studies were at a high risk of bias and should be considered cautiously.</s><s xml:id="_2yJSGV5">To provide context for readers interpreting our findings, we have denoted the level of bias as either low risk (LRB) or high risk (HRB) throughout the subsequent results sections.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3." xml:id="_2X9pb6q">Patient Satisfaction</head><p xml:id="_9wYU2N3"><s xml:id="_7nwyXTM">Twelve studies (67%) reported outcomes related to patient satisfaction (Table <ref type="table" target="#tab_5">2</ref>).</s><s xml:id="_nDSk9dR">Overall, patient satisfaction with the text-based interventions was high.</s><s xml:id="_zQZmAEx">For example, Bade et al. <ref type="bibr" target="#b33">[35]</ref> reported that 92% of patients found a twice-daily motivational text communication service helpful for improving their physical activity (HRB).</s><s xml:id="_Y5G9nAq">In a pilot study of text messages for self-care and emotional support (sent using the cHEmotHErAPP), Rico et al. <ref type="bibr" target="#b37">[39]</ref> reported that all patients felt they could better cope with their cancer treatment through feelings of increased confidence and knowledge (LRB).</s><s xml:id="_yTGU2pU">Similarly, a two-armed, prospective, singlecenter RCT of the same intervention reported a patient satisfaction rate of 100% in the intervention group, where 72% were very satisfied and 28% were satisfied (HRB) <ref type="bibr" target="#b28">[30]</ref>.</s><s xml:id="_8CFAbnC">Krok-Schoen and colleagues <ref type="bibr" target="#b10">[11]</ref> conducted a pre-post study of daily text message reminders to improve hormone therapy adherence among breast cancer patients and found that 97% had a positive experience (HRB).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4." xml:id="_5Rqzbrn">Barriers to the Use of Text-Based Communication</head><p xml:id="_F8NrQpr"><s xml:id="_w4ygUwS">Seven studies (39%) reported barriers to the use of text-based communication (Table <ref type="table" target="#tab_5">2</ref>).</s><s xml:id="_Q3Hee35">Three of those studies <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b25">27,</ref><ref type="bibr" target="#b36">38]</ref> reported barriers to text-based communication adherence, which included scheduling conflicts, forgetfulness, feeling unwell, not liking the language used in the messages, and not feeling well enough to continue without the messages <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b25">27]</ref>.</s><s xml:id="_buVcvHb">The study by Mougalian and colleagues <ref type="bibr" target="#b36">[38]</ref> was the only study to document cost-related outcomes, where over 70% of patients had no financial impact associated with the textbased communications (HRB).</s><s xml:id="_KKwWAqD">Three studies <ref type="bibr" target="#b31">[33,</ref><ref type="bibr" target="#b32">34,</ref><ref type="bibr" target="#b35">37]</ref> identified technological barriers to completing the intervention, and overall reported few technological problems.</s><s xml:id="_CaZg48s">For example, Spoelstra et al. <ref type="bibr" target="#b32">[34]</ref> found that just 5.3% of patients encountered problems with the medication adherence text messaging system in their two-armed, prospective, multi-center RCT (LRB).</s><s xml:id="_qpURujU">Lastly, two studies <ref type="bibr" target="#b35">[37,</ref><ref type="bibr" target="#b40">42]</ref> reported barriers to study recruitment, which included poor health status, lack of familiarity/confidence with the technology, and perceived lack of need for additional supportive interventions (HRB, HRB respectively).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5." xml:id="_PpHCyZE">Symptom Outcomes</head><p xml:id="_QKGwzWG"><s xml:id="_8YD6QvT">Six studies (33%) examined symptoms (Table <ref type="table" target="#tab_6">3</ref>).</s><s xml:id="_Vpn2p6j">Overall, results for composite symptom scores were mixed while symptom-specific results were not significantly different between study groups.</s><s xml:id="_3gR4c2F">In terms of composite scores, Rico et al. <ref type="bibr" target="#b28">[30]</ref> found that the total number of side effects from cycle one of chemotherapy was significantly lower in the text-based communication group compared to those receiving standard care (number of patients experiencing 4-14 side effects in intervention (I) vs. control (C) groups: n = 28 vs. 42, p = 0.05, HRB), but this was not seen in the following two chemotherapy cycles (cycle 2: p = 0.4, cycle 3: p = 0.4).</s><s xml:id="_jnDMCdW">Conversely, Krok-Schoen et al. <ref type="bibr" target="#b10">[11]</ref> found no significant difference in mean Breast Cancer Prevention Trial Symptom Checklist score post treatment with text-based communication vs. baseline (mean difference (MD) (post-baseline) 0.04, 95%CI -0.06 to 0.14, p = 0.412, HRB).</s><s xml:id="_sK4PDQm">Despite the heterogeneity between studies, positive results were found in specific settings such as Spoelstra et al. <ref type="bibr" target="#b31">[33]</ref>.</s><s xml:id="_mbwudJv">This study <ref type="bibr" target="#b31">[33]</ref> was a two-armed, prospective, multi-center RCT examining a population of patients with various forms of cancer and newly prescribed oral anticancer medication.</s><s xml:id="_FN8TwRb">A significant reduction in mean total number of symptoms was reported among those receiving daily medication adherence text messages compared to those who did not (I vs. C mean 3.9 SD 0.5 vs. 5.</s><s xml:id="_4NYgYKE">SD 0.46, p = 0.04, LRB).</s><s xml:id="_3UTDJXV">All intervention patients attended both tailoring sessions and received text messages for the first 4 weeks of the program, however 4 participants opted out from receiving texts for the last 8 weeks (reasons included: n = 1 sufficiently self-motivated to continue without texts, n = 1 not finding texts useful, n = 1 overseas travel, n = 1 not liking the directive language of the texts)</s></p><p xml:id="_96WgfVj"><s xml:id="_Getp5de">Rico, 2020 <ref type="bibr" target="#b28">[30]</ref> 72.1% reported being very satisfied Spoelstra, 2016 <ref type="bibr" target="#b32">[34]</ref> 92% reported satisfaction (very much/highly satisfied)</s></p><p xml:id="_eGVPx5X"><s xml:id="_PrbV4dn">5.3% encountered problems with the text message system Spoelstra, 2015 <ref type="bibr" target="#b31">[33]</ref> All were somewhat (n = 2) or highly (n = 35) satisfied with their participation in the study 7/37 encountered a problem with automated voice recordings, 1/36 encountered a problem with texts Tan, 2020 <ref type="bibr" target="#b29">[31]</ref> Overall most patients agreed that text messages were easy to understand (99.2%)</s></p><p xml:id="_CWUqpHk"><s xml:id="_TUAeQjx">Non-Randomized Interventional/Observational Studies Bade, 2018 <ref type="bibr" target="#b33">[35]</ref> 92% of patients found intervention helpful (out of n = 13) Chow, 2019 <ref type="bibr" target="#b34">[36]</ref> Mean USE scale score was 6.9/7 for ease of use, 6.9/7 (SD 0.4) for ease of learning, and 6.5/7 (SD 0.3) for satisfaction Krok-Schoen, 2019 <ref type="bibr" target="#b10">[11]</ref> 97.3% of patients reported a positive experience (out of n = 37) 12/39 did not complete the intervention for the following reasons: being busy, not feeling well, or forgetfulness Maguire, 2015 <ref type="bibr" target="#b35">[37]</ref> All patients agreed the handset helped them manage symptoms and communicate with the physician/nurses 100% reported that they encountered problems in using the handset Mougalian, 2017 <ref type="bibr" target="#b36">[38]</ref> 73% of respondents reported that the text messages helped them take their medication either very much or quite a lot.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_tcbXyMG">4.7% of respondents felt the intervention took up too much time</head><p xml:id="_b6RA3QK"><s xml:id="_rWXmkGW">Rico, 2017 <ref type="bibr" target="#b37">[39]</ref> n = 15 reported being satisfied or very satisfied Wells, 2020 <ref type="bibr" target="#b40">[42]</ref> Of the 13 patients who used smart messaging and were interviewed found smart messages to be a prompt and reminder, some also found it motivating or drew patients back to mindfulness, second theme of personal connection was found (i.e., "someone is thinking about me") even when patient knew the message wasn't personally sent Two patients explained opting out due to lack of confidence in mobile phones a Patient satisfaction outcomes: The following hierarchy was used to determine which patient satisfaction outcomes to include in the table:</s></p><p xml:id="_NkQ4yPh"><s xml:id="_xm3sxr9">(1) overall satisfaction, (2) text message-specific satisfaction.</s><s xml:id="_rjEBgrG">b Barrier outcomes: The following hierarchy was used to determine which barriers outcomes to include in the table : (1) barriers related to the intervention, (2) barriers related to recruitment.</s><s xml:id="_BTYNfRM">Abbreviations: usability, satisfaction, and ease of use (USE).</s><s xml:id="_e4qmkKr">Note: outcome sample sizes are equal to sample sizes at baseline unless otherwise specified.</s><s xml:id="_C8M6pan">For all outcomes, when multiple time points were recorded, we reported the longest available follow-up.</s><s xml:id="_KDXgQJG">-0.5 IQR 1.5, 0 (n = 10); p = 0.035 between I and C1</s></p><p xml:id="_5zsFtQg"><s xml:id="_PtdGMeR">Rico, 2020 [30] Number of patients experiencing side effects experienced in cycle 3, I vs. C: 0-3 side effects 19 vs. 15, 4-14 side effects 24 vs. 29, p = 0.38 Spoelstra, 2016 [34] Mean total number of symptoms in I vs. C: 4.9 SD 0.4 vs. 5.2 SD 0.6, p = 0.7 (ES 0.09) Mean PROMIS Physical function score in I vs. C: 45.7 SD 0.9 vs. 45.7 SD 1.3, p = 0.99 (ES 0); Mean PROMIS Depression score in I vs. C: 44.6 SD 1.0 vs. 44.2</s><s xml:id="_D2ctx7q">SD 1.3, p = 0.8 (ES 0.06) Spoelstra, 2015 [33] Mean total number of symptoms in I vs. C: 3.9 SD 0.5 vs. 5.3 SD 0.5, p = 0.04 (ES 0.5) Mean PROMIS Physical function score in I vs. C: 47.6 SD 1.2 vs. 44.9</s><s xml:id="_x9XFJV8">SD 1.1, p = 0.1 (ES 0.4); Mean PROMIS Depression score in I vs. C: 44.7 SD 1.3 vs. 44.9</s><s xml:id="_4rj4nzk">SD 1.2, p = 0.9 (ES 0.03) Villaron, 2018 [32] Mean QLQ-30 Physical capacity score at Week 8 in I vs. C: 88.2 SD 13.6 vs. 83.6</s><s xml:id="_J6zJ5ax">SD 12.7, p = 0.3; Mean MFI-20 Mental fatigue score at Week 8 in I vs. C: 6.9 SD 3.8 vs. 10.0</s><s xml:id="_fEH7Pvy">SD 4.2, p &lt; 0.05 Non-Randomized Interventional/Observational Studies Bade, 2018 [35] Mean daily step count Week 0 vs. Week 3: I group (n = 15) 4906.1 SD 256.8 vs. 5241.2</s><s xml:id="_PF3bsYZ">SD 291.7 (ES 0.02); C group (n = 22) 5128.2</s><s xml:id="_3f4WpM4">SD 223.7 vs. 5247.2</s><s xml:id="_TsquZxP">SD 242.9 (ES 0.05) Chow, 2019 [36] Mean PHQ-4 score was 1.7 SD 2.3 (n = 9 reported at least a moderate level of distress â¥ 6 at any point) Krok-Schoen, 2019 [11] Mean Breast Cancer Prevention Trial Symptom Checklist score not significantly different between I vs. C (n = 37): 0.8 SD 0.5 vs. 0.7 SD 0.5, MD (I-C) 0.04, 95% CI -0.06, 0.1, p = 0.4 Mean SF-8 physical health component score I vs. C (n = 36): 46.4 SD 10.6 vs. 45.4</s><s xml:id="_wS8xDHC">SD 10.3, MD (I-C) 1.0, 95% CI -1.7, 3.6, p = 0.4; Mean SF-8 mental health component score I vs. C (n = 36): 53.0 SD 6.5 vs. 49.9</s><s xml:id="_J9kePvq">SD 7.8, MD (I-C) 3.0, 95% CI 0.9, 5.1, p = 0.007 Maguire, 2015 [37] Median ESAS nausea score in I vs. C (n = 16): 2, range 0-6 vs. 0, range 0-8 Median ESAS depression score in I vs. C (n = 16): 0, range 0-8 vs. 0, range 0-8 Mougalian, 2017 [38] Number of patients reporting any symptoms for Tamoxifen patients vs. AI patients vs. all patients: 35 vs. 56 vs. 91 (p = 0.20 for Tamoxifen vs. AI patients) Wells, 2020 [42] Depression (PHQ-9) reduced by 2.3 points (95% CI: 0.76-3.89)</s><s xml:id="_atzy3nY">p = 0.004 a Symptom outcomes: The following hierarchy was used to determine which symptom outcome to include in the table: (1) composite symptom scores, (2) nausea if acute population or pain if follow-up population (3) fever if acute population or shortness of breath if follow-up population, (4) other relevant outcomes.</s><s xml:id="_9YXVepv">b QoL outcomes: The following hierarchy was used to determine which QoL outcomes to include in the table: (1) QoL outcome if present, (2) one physical health outcome (functional status, physical activity, diet) and one mental health outcome (mood, depression anxiety).</s><s xml:id="_nhG77mg">Abbreviations: aromatase inhibitor (AI), confidence interval (CI), control group (C), effect size (ES), Edmonton Symptom Assessment System (ESAS), intervention group (I), interquartile range (IQR), mean difference (MD), Multidimensional Fatigue Inventory (MFI), Patient Health Questionnaire (PHQ), Patient-Reported Outcomes Measurement Information System (PROMIS), quality of life (QoL), Quality of Life Questionnaire (QLQ), standard deviation (SD), short form (SF). Note: outcome sample sizes are equal to sample sizes at baseline unless otherwise specified.</s><s xml:id="_Y9z3FCh">For all outcomes, when multiple time points were recorded, we reported the longest available follow-up.</s></p><p xml:id="_4UnVWMD"><s xml:id="_3RP4rbP">Among symptom-specific results, Krok-Schoen et al. <ref type="bibr" target="#b10">[11]</ref> found no significant change in mean Brief Pain Inventory Score (MD (I-C) 0.8, 95% CI -0.4 to 2.02, p = 0.2) or mean Fatigue Symptom Inventory (MD (I-C) -0.3, 95% CI -0.8 to 0.3, p = 0.3) from posttreatment vs. baseline (HRB).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.6." xml:id="_dfBtBPV">Quality of Life Outcomes</head><p xml:id="_4jfGGzk"><s xml:id="_PV8geJn">A total of ten studies (56%) examined the QoL outcomes (Table <ref type="table" target="#tab_6">3</ref>).</s><s xml:id="_pzjtDTx">Of these, six studies <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b25">27,</ref><ref type="bibr" target="#b26">28,</ref><ref type="bibr" target="#b30">32,</ref><ref type="bibr" target="#b33">35,</ref><ref type="bibr" target="#b35">37]</ref> examined the physical health outcomes including step counts, physical activity change, physical fatigue, and self-care change.</s><s xml:id="_guy8Xs4">Of the two studies that reported step counts one found no consistent change in steps in the text-based communication vs.no text communication groups over an 8-week period (HRB) <ref type="bibr" target="#b30">[32]</ref>, while the other found that mean daily steps significantly increased for both the text-based communication and weekly phone call groups over a 3 week period compared to controls (effect sizes 0.02 and 0.05, respectively, HRB) <ref type="bibr" target="#b33">[35]</ref>.</s><s xml:id="_hG4gyq5">Physical activity change was reported by two studies and mixed results were found.</s><s xml:id="_gUwvS3B">In their single-center prospective RCT, Gomersall et al. <ref type="bibr" target="#b25">[27]</ref> reported an increase in physical activity among those receiving text-based communication versus those undergoing a 4-week exercise rehabilitation without texts (mean time light stepping, change score MD (I-C) 6.9, 95% CI 0.8, 12.9, p = 0.03, LRB).</s><s xml:id="_QHPaBjZ">Physical component scores from various questionnaires (Functional Assessment of Cancer Therapy-Lung (FACT-L), Short Form Health Survey (SF-8), Quality of Life Questionnaire (QLQ-30), Patient-Reported Outcomes Measurement Information System (PROMIS)) reported mixed results.</s><s xml:id="_P4RpKA2">Krok-Schoen et al. <ref type="bibr" target="#b10">[11]</ref> found that physical health, as reported by the SF-8, was better at post-treatment vs.baseline, though this difference was not significant (MD (I-C) 0.95, 95% CI -1.71 to 3.61, p = 0.473, HRB).</s><s xml:id="_v7sMxgc">In their single-center RCT, Villaron et al. <ref type="bibr" target="#b30">[32]</ref> reported significant results for the physical capacity of the QLQ-30, finding increased capacity among those receiving text-based communication vs.no text messages.</s><s xml:id="_XzrmrHe">However, their results were significant only within 7 weeks of follow-up (I vs. C: mean 88.3 SD 13.5 vs. 75.5</s><s xml:id="_2RuNt8e">SD 18.9, p &lt; 0.01, HRB).</s></p><p xml:id="_EfCxz7e"><s xml:id="_97Cf3Gu">Seven <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b30">[32]</ref><ref type="bibr" target="#b31">[33]</ref><ref type="bibr" target="#b32">[34]</ref><ref type="bibr" target="#b34">36,</ref><ref type="bibr" target="#b35">37,</ref><ref type="bibr" target="#b40">42</ref>] studies looked at an array of mental health outcomes including depression, anxiety, motivation, and emotional well-being (Table <ref type="table" target="#tab_6">3</ref>).</s><s xml:id="_pFSXy9G">Depression was the most highly reported outcome (33% <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b31">33,</ref><ref type="bibr" target="#b32">34,</ref><ref type="bibr" target="#b34">36,</ref><ref type="bibr" target="#b35">37,</ref><ref type="bibr" target="#b40">42]</ref> studies), and results were varied.</s><s xml:id="_TR4KKks">In their multi-center RCTs, Spoelstra et al. <ref type="bibr" target="#b32">[34]</ref> and Spoelstra et al. <ref type="bibr" target="#b31">[33]</ref> both found no significant difference in PROMIS depression scores among those receiving text-based communication vs.standard care (p = 0.8, p = 0.9, respectively, LRB).</s><s xml:id="_PfKKVy5">Krok-Schoen and colleagues <ref type="bibr" target="#b10">[11]</ref> found those who received texts to prompt medication adherence had lower Center of Epidemiology Study-Depression (CESD-D) score compared to baseline scores (MD -1.2, 95% CI -3.5, 1.01, p = 0.3, HRB).</s><s xml:id="_V5CXyQn">Similar results were found with anxiety outcomes; Wells et al. <ref type="bibr" target="#b40">[42]</ref> reported a trend for greater improvement in anxiety among those receiving text-based communication to support mindfulness-based cognitive therapy (MBCT) (p &lt; 0.001, HRB), however this did not significantly differ from those receiving MBCT without the additional supportive texts.</s></p><p xml:id="_pdHvCEc"><s xml:id="_y93jX3m">Among patients undergoing outpatient chemotherapy or systemic treatment for various forms of cancer, Villaron et al. <ref type="bibr" target="#b30">[32]</ref>'s RCT found significantly lower decline in motivation (I vs. C week 8 mean 7.88 SD 3.74 vs. 10.73</s><s xml:id="_TdFUA2A">SD 3.87 p &lt; 0.05), activity (I vs. C week 8 mean 8.24 SD 4.09 vs. 11.82</s><s xml:id="_DrdBP7Y">SD 4.16 p &lt; 0.01), and both mental (I vs. C week 8 mean 6.94 SD 3.77 vs. 9.95 SD 4.19 p &lt; 0.05), and physical functioning (I vs. C week 8 mean 9.76 SD 4.63 vs. 12.27 SD 4.63 p &lt; 0.05) among those receiving text-based communication that provided motivation to encourage physical activity vs. those receiving no text messages (HRB).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.7." xml:id="_FUSXHcG">Feasibility and Implementation Outcomes</head><p xml:id="_sF8WTsx"><s xml:id="_mm96Rma">Sixteen studies (89%) examined feasibility or implementation outcomes (Table <ref type="table">4</ref>).</s><s xml:id="_3WUvfNt">A variety of feasibility outcomes were reported, including adherence to the intervention and medications, number of text messages sent, text-message response rate, and odds of completing the intervention.</s><s xml:id="_rPXRtqJ">Seven studies <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b27">29,</ref><ref type="bibr" target="#b29">31,</ref><ref type="bibr" target="#b32">34,</ref><ref type="bibr" target="#b36">38,</ref><ref type="bibr" target="#b38">40]</ref> reported adherence to prescribed medications or therapy, with mixed results.</s><s xml:id="_ZMkFqpW">Three studies reported an adherence rate &gt; 50% <ref type="bibr" target="#b29">[31,</ref><ref type="bibr" target="#b36">38,</ref><ref type="bibr" target="#b38">40]</ref> (HRB, HRB, LRB, respectively) among those receiving text-based communication.</s><s xml:id="_UrgY8Vp">Conversely, one study found adherence of &lt;50% <ref type="bibr" target="#b27">[29]</ref> among those receiving text-based communication (LRB).</s><s xml:id="_fSNemJM">Those that examined the medication adherence between study groups found mixed results.</s><s xml:id="_Cae8xxv">One study <ref type="bibr" target="#b10">[11]</ref> found control groups not receiving texts to have higher adherence scores compared to the text-message intervention group (p &lt; 0.05, HRB) while two studies <ref type="bibr" target="#b29">[31,</ref><ref type="bibr" target="#b38">40]</ref> found that the text-based communication groups had higher adherence levels (p &lt; 0.05, HRB).</s></p><p xml:id="_cxd5cEQ"><s xml:id="_aErNYbN">Table 4. Feasibility and implementation outcomes (n = 16 studies).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NCy7uUV">Author, Year</head><p xml:id="_NmDUS5g"><s xml:id="_xAggnQf">Feasibility Outcomes a</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_RrUtWV5">Randomized Trials</head><p xml:id="_VGaV7Xe"><s xml:id="_wmEYSBh">Casillas, 2019 <ref type="bibr" target="#b24">[26]</ref> Mean survivorship care knowledge scale total score (range 1-5) in I vs. C1 vs. C2: 3.8 SD 0.9 pre, 4.2 SD 0.8 post (within-group p &lt; 0.05) vs. 4.0 SD 0.9 pre, 4.1 SD 0.8 post (within-group p = 0.38); 3.5 SD 0.8 pre, 3.4 SD 0.6 post (within-group p = 0.67), p &lt; 0.05 for I vs. C2 (ES 0.7), p = 0.07 (ES 0.3) for C1 vs. C2</s></p><p xml:id="_wNGYtTc"><s xml:id="_mTMXJCm">Gomersall, 2019 <ref type="bibr" target="#b25">[27]</ref> 83% (n = 31) of patients attended all four exercise sessions Hershman, 2020 <ref type="bibr" target="#b27">[29]</ref> Medication adherence failure (based on urine samples, accounting for censoring) in I vs. C: total 283 vs. 303 events, HR 0.9, 95% CI 0.8, 1.1, p = 0.2 Rico, 2020 <ref type="bibr" target="#b28">[30]</ref> 52 text messages were sent from day 1 to the beginning of cycle 4</s></p><p xml:id="_jKWZUX7"><s xml:id="_xCqhcMt">Spoelstra, 2016 <ref type="bibr" target="#b32">[34]</ref> Mean adherence to OA in I vs. C: 6.5 SD 0.4 vs. 7.2 SD 0.5, p = 0.3 (ES 0.3) Spoelstra, 2015 <ref type="bibr" target="#b31">[33]</ref> Overall mean adherence in I vs. C: 6.0 SD 0.5 vs. 6.0 SD 0.</s></p><p xml:id="_eW54fjz"><s xml:id="_D6eRgUS">5, p = 1 (ES 0); 1359 texts were sent to patients (1111 adherence, 116 symptom management, 52 additional, 53 welcome and 17 end of study) Tan, 2020 [31] SMAQ adherence in I vs. C vs. All: 52.0% vs. 54.6% vs. 53.3%</s><s xml:id="_TR8BYGd">Villaron, 2018 [32] Survey compliance was 64.6% Non-Randomized Interventional/Observational Studies Bade, 2018 [35] Number of patients never using the device in I vs. C: 0% vs. 21% (out of n = 15 vs. n = 29) Chow, 2019 [36] Screener adherence rate was 75% Krok-Schoen, 2019 [11] Mean Morisky Adherence score in I vs. C (n = 36): 1.2 SD 1.3 vs. 1.9 SD 1.7, MD (I-C) -0.8, 95% CI -1.4,</s><s xml:id="_qQm53K8">-0.2, p = 0.02 Maguire, 2015 [37] 182 alerts were generated over 12 months (138 amber, 44 red) Mougalian, 2017 [38] 86.1% of patients responded to all the daily texts (among those who completed the pilot study, response rate was 92.2%);</s><s xml:id="_hhYe9yJ">Average of 10 min/week was spent using the application Sawicki, 2019 [40] 40% response rate to texts requiring a response; Optimal adherence in I vs. C: 53.4% vs. 43.7%</s><s xml:id="_UDJ5sRA">(difference 9.7%, p = 0.02) Tan, 2019 [41] No show rate in C vs. I: adjusted OR 6.8, 95% CI 5.5, 8.4, p &lt; 0.0001 Wells, 2020 [42] Odds of completing MBCT in I vs. C: 87% vs. 38%, p = 0.007, adjusted OR 7.8, 95% CI 1.8, 34.6 a Feasibility outcomes: The following hierarchy was used to determine which feasibility outcomes to include in the table: (1) one patientlevel outcome and one systems-level outcome if available.</s><s xml:id="_7uEJ3Ut">Abbreviations: confidence interval (CI), control group (C), effect size (ES), intervention group (I), mean difference (MD), mindfulness-based cognitive therapy (MBCT), odds ratio (OR), oral anticancer (OA), standard deviation (SD), Simplified Medication Adherence Questionnaire (SMAQ).</s><s xml:id="_82b2Ggz">Note: outcome sample sizes are equal to sample sizes at baseline unless otherwise specified.</s><s xml:id="_X9uKfXd">For all outcomes, when multiple time points were recorded, we reported the longest available follow-up.</s></p><p xml:id="_5585jgw"><s xml:id="_4XHTuXN">On a systems level, number of text messages sent was the most ubiquitous feasibility outcome <ref type="bibr" target="#b25">[27,</ref><ref type="bibr" target="#b28">30,</ref><ref type="bibr" target="#b31">33,</ref><ref type="bibr" target="#b36">38]</ref>.</s><s xml:id="_s4DdqFK">Number of text messages sent ranged from 52 messages over 3 cycles of chemotherapy (LRB) <ref type="bibr" target="#b28">[30]</ref> to 21 messages sent per week (HRB) <ref type="bibr" target="#b36">[38]</ref>.</s><s xml:id="_bBr38gK">Outcomes such as text message response rates and number of alerts generated were reported by fewer studies.</s><s xml:id="_EGDQeVW">Text message response rate ranged from 40% (HRB) <ref type="bibr" target="#b38">[40]</ref> to 86.1% (HRB) <ref type="bibr" target="#b36">[38]</ref> among studies in which it was reported <ref type="bibr" target="#b25">[27,</ref><ref type="bibr" target="#b36">38,</ref><ref type="bibr" target="#b38">40]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4." xml:id="_BNuk8UH">Discussion</head><p xml:id="_emWPPQA"><s xml:id="_UPC3wjE">In this systematic review of text-based communications in cancer-supportive care, we find that text-based communication tools are a potentially feasible intervention that tends to improve patient satisfaction, with heterogenous but no detrimental effect on symptom or QoL outcomes.</s><s xml:id="_CFSeXNs">However, the majority of studies included in this review were judged to be at a high risk of bias, suggesting that our results should be interpreted with caution.</s><s xml:id="_AJvtfyQ">These findings help establish the role of text-based communication in cancer-supportive care and provide a benchmark for implementation in cancer-care facilities.</s><s xml:id="_pddeTuM">They also highlight the need for future, well-designed studies.</s></p><p xml:id="_sRb3CFs"><s xml:id="_bqkd3VD">Text-based communication is a pragmatic virtual care tool, enabling real-time bidirectional communication between provider and patient at a low cost and in an accessible format <ref type="bibr" target="#b41">[43,</ref><ref type="bibr" target="#b42">44]</ref>.</s><s xml:id="_DSM3JAH">Amid heterogeneous results, we identified potential support for the use of text-based interventions within specific settings.</s><s xml:id="_CXe8Umk">For example, providing a specific call to action (e.g., for medication adherence or appointment attendance) via text-based communication may be successful in producing the desired behavior change <ref type="bibr" target="#b29">[31,</ref><ref type="bibr" target="#b38">[40]</ref><ref type="bibr" target="#b39">[41]</ref><ref type="bibr" target="#b40">[42]</ref>, thereby potentially translating to improved clinical outcomes <ref type="bibr" target="#b31">[33,</ref><ref type="bibr" target="#b32">34]</ref>.</s><s xml:id="_K324VjZ">Similar text-driven behavioral changes have been seen among other chronic disease populations.</s><s xml:id="_pNg66Mf">A metaanalysis looking specifically at text-messaging for medication adherence in chronic diseases reported a significant improvement in medication adherence compared to those without text-messages <ref type="bibr" target="#b6">[7]</ref>.</s><s xml:id="_XjNqex3">Our findings also suggest that when interventions facilitate selfmanagement, improvements in fatigue and QoL outcomes can occur.</s><s xml:id="_fGsRfSd">This may be due to the nature of self-management interventions, which usually include an information-based component aimed at building self-efficacy, known as a key causal mechanism for behavior change and improved health outcomes <ref type="bibr" target="#b43">[45]</ref>.</s><s xml:id="_XxU9Ycz">Notably, many of these positive outcomes were seen in the RCTs as opposed to the non-RCTs, indicating a higher quality of evidence in support of text-based communication feasibility.</s></p><p xml:id="_uBB5ZbH"><s xml:id="_XXvAr2y">Our review suggests that text-based communication interventions were consistently associated with high levels of patient satisfaction and produced no harmful effects.</s><s xml:id="_9FFaP3a">The majority of studies reported positive patient satisfaction outcomes such as improved self-management skills, increased confidence and knowledge, and general feelings of positivity.</s><s xml:id="_2RUpkEc">Further, patients reported that text-based communications were helpful and easy-to-understand.</s><s xml:id="_hHEtAjr">These findings align with the existing research; a recent systematic review of telehealth interventions found that patient satisfaction outcomes were generally positive <ref type="bibr" target="#b44">[46]</ref>.</s><s xml:id="_SV94q9r">Notably, only one included study assessed intervention costs, showing no added cost to the patient with text-based communication <ref type="bibr" target="#b36">[38]</ref>.</s><s xml:id="_sdG5YKP">This was unsurprising, given that the literature is sparse regarding cost-effectiveness of text-based interventions <ref type="bibr" target="#b42">[44,</ref><ref type="bibr" target="#b45">47]</ref>.</s><s xml:id="_7tDrYVV">While more research is needed, high patient satisfaction suggests that text-based interventions are well-accepted and may help to reduce some of the patient-perceived barriers to care.</s></p><p xml:id="_nvZDSdc"><s xml:id="_E8ZfQQY">We observed an overall lack of evidence for understanding the real-world effectiveness of text-based communication.</s><s xml:id="_ZHb2Fzu">Although 89% of included studies reported on feasibility, the included outcomes were highly heterogeneous and few assessed the practicality of implementing this technology.</s><s xml:id="_ecP56rN">Thus, future studies should utilize standardized methods for study design and outcome reporting, facilitating inter-study comparison.</s><s xml:id="_uR9A8Ka">Researchers should consider the use of the Research, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework to identify meaningful study outcomes for determining the real-world success of text-based interventions <ref type="bibr" target="#b46">[48]</ref>.</s><s xml:id="_82wZM4Z">When studying text-based communications, it is important to understand factors affecting their uptake.</s><s xml:id="_VAzKmH5">Therefore, we also propose the use of effectiveness-implementation hybrid study designs, which facilitate timely adoption of a given clinical intervention through the simultaneous study of both its effectiveness and uptake <ref type="bibr" target="#b47">[49]</ref>.</s><s xml:id="_9n3JsJp">Moving forward, these tools will help guide researchers in identifying meaningful outcomes for studying text-based communications in cancer-supportive care.</s></p><p xml:id="_QpytTQz"><s xml:id="_yKwKNqZ">Our review identified a clear lack of evidence from LMICs.</s><s xml:id="_SJp6nsR">Of the 18 included studies, only 2 (11%) took place in a single LMIC (Brazil, an upper-middle-income country).</s><s xml:id="_Qmw5DKV">Similarly, in their review of mobile technologies in cancer care, Nasi and colleagues <ref type="bibr" target="#b21">[22]</ref> identified a total of 106 studies, of which only 13 (12%) focused on LMICs.</s><s xml:id="_fGduntM">Comparable trends also exist in the broader cancer literature.</s><s xml:id="_bQ645rK">A retrospective analysis of all phase 3 treatment studies published from 2014-2017 (n = 694 RCTs) found that just 8% were led by LMIC investigators <ref type="bibr" target="#b48">[50]</ref>.</s><s xml:id="_2Jt5x85">LMICs experience high cancer incidence as well as disproportionately high mortality <ref type="bibr" target="#b49">[51]</ref>.</s><s xml:id="_BNsu7mB">For example, in 2020 Asia reported 49.3% of global cancer cases and a disproportionate 58.3% of deaths <ref type="bibr" target="#b50">[52]</ref>.</s><s xml:id="_tNcm9d3">As of 2015, approximately 8 in 10 individuals in developing countries owned a mobile phone <ref type="bibr" target="#b51">[53]</ref>.</s><s xml:id="_83Bc2zd">Thus, future research efforts should focus on testing the feasibility, acceptability, and effectiveness of text-based communication in LMICs.</s></p><p xml:id="_nntkn6p"><s xml:id="_vK5jR9Q">In the context of the pandemic, the use of telemedicine is gaining global popularity globally including in LMICs <ref type="bibr" target="#b52">[54]</ref>.</s><s xml:id="_KuVsHZR">This study captured both high-quality RCTs and realworld observational studies.</s><s xml:id="_BsKwa5G">Although none of the studies included in our review were conducted in the context of the pandemic, this review will provide a benchmark for better integrating supportive care for cancer patients in HICs and LMICs using a text-based communication both during and after the pandemic.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_DdWzdQZ">Strengths and Limitations</head><p xml:id="_aTyhp3d"><s xml:id="_8fxX3UY">Our review captured both interventional and observational study designs.</s><s xml:id="_UpwTDp2">While interventional studies provide a higher standard of evidence, observational studies are useful for understanding the long-term and real-world outcomes.</s><s xml:id="_g4fnnCe">Additionally, our review focused on studies published in the past 5 years making our results timely and topical.</s><s xml:id="_zR9EYmr">We also performed a bias assessment of the included studies using validated risk of bias tools <ref type="bibr" target="#b22">[24,</ref><ref type="bibr" target="#b23">25]</ref>.</s><s xml:id="_mszWRwv">This allowed us to identify those studies at a high risk of bias and interpret their findings accordingly.</s><s xml:id="_UmjQuBW">Lastly, the potential for selection bias was reduced due to a rigorous study screening process.</s></p><p xml:id="_RSAUwq2"><s xml:id="_vmADs8r">A limitation of this review was the substantial heterogeneity observed between studies regarding their population of interest, intervention design, outcome reporting, and followup duration.</s><s xml:id="_P7qgcJT">This heterogeneity may be due, in part, to the variety of phases in the healthcare process captured by this review.</s><s xml:id="_5XN4D4s">As demonstrated by Nasi et al. <ref type="bibr" target="#b21">[22]</ref>, text-based interventions can be employed at any phase of cancer care.</s><s xml:id="_hHy9kqC">Our review focused on the treatment and follow-up periods, two phases that tend to highlight different outcome types.</s><s xml:id="_P3kQvBZ">Methodological standardization using tools such as the effectiveness-implementation study design and RE-AIM framework may help improve comparability of future works.</s><s xml:id="_v79gWj2">In addition, several included studies were likely underpowered, with a limited ability to detect differences between treatment groups.</s><s xml:id="_Zu8KJ5f">Six non-randomized interventional studies were identified serious risk of bias and two RCTs were identified as high risk of bias.</s><s xml:id="_jv4GGtu">Including outcomes reported by these studies regarding the feasibility and effectiveness of text-based communications may have prevented accurate conclusions from being drawn.</s><s xml:id="_gczGXAp">As most studies included had short follow-up periods, the findings of this review cannot speak for long-term effects of text-based communication.</s><s xml:id="_FUTxP7b">Additionally, the needs of patients with chronic diseases vary greatly, limiting to the generalizability of these results beyond patients with cancer.</s><s xml:id="_KdJMPew">Lastly, for feasibility reasons our search was restricted to studies written in the English language and we did not conduct a search for grey literature.</s><s xml:id="_SGE5z9j">This may have limited our search and excluded relevant studies from inclusion.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5." xml:id="_aA2Hs43">Conclusions</head><p xml:id="_ADZmmfC"><s xml:id="_ZyNDkgv">In conclusion, text-based intervention in cancer-supportive care trends toward high levels of patient satisfaction, suggesting that this may be an acceptable tool for augmenting supportive care.</s><s xml:id="_GsgSbqd">Although findings were inconsistent regarding the effects of text-based communications on patient symptoms, QoL, and feasibility/implementation, we observed the potential success of text-based communication within specific settings.</s><s xml:id="_AbHaJjT">More research is needed to identify what is needed to achieve a successful text-based intervention.</s><s xml:id="_5TrZycs">Given its low costs and more equitable coverage, text-based communication has the potential to improve global cancer care.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Cancers 2021, 13 , 4 of 19 Figure 1 .</head><label>13191</label><figDesc><div><p xml:id="_uSSpcMR"><s xml:id="_cwPP2sq">Figure 1.</s><s xml:id="_8ySRcNj">PRISMA flow diagram.</s></p></div></figDesc><graphic coords="4,173.64,315.89,341.52,354.96" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_UtwzByK"><s xml:id="_6ucqGUp">Figure 1.</s><s xml:id="_A25mM6a">PRISMA flow diagram.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Median 6 -</head><label>6</label><figDesc><div><p xml:id="_mdfXQc8"><s xml:id="_jhxY89k">month change score for SF-12 physical health component in I vs. C1 vs. C2: 0.9 IQR -0.7-4.8 (n = 11) vs. 5.4 IQR 3.8-15.0</s><s xml:id="_RhZtumv">(n = 11) vs. 7.4 IQR 1.8-11.0</s><s xml:id="_QQmVgKf">(n = 10); p = 0.04 between I and C1; Median 6-month change score for Multidimensional Body Self Relations Questionnaire-Appearance subscale in I vs. C1 vs. C2: 0.0 IQR -1.0, 0.0 (n = 11) vs. -3.5 IQR -5.0, -1.0 (n = 11) vs.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_5qCAk69"><s xml:id="_EwkBWan">Study characteristics (n = 18 studies).</s></p></div></figDesc><table><row><cell>Author</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_f2K3xKy"><s xml:id="_C5cxpV6">Study characteristics (n = 18 studies).</s></p></div></figDesc><table><row><cell>Author</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_rMfuwgQ"><s xml:id="_BpCkBVW">Cont.</s></p></div></figDesc><table><row><cell>Author, Year (Country)</cell><cell>Study Design</cell><cell>Study Population, Sample Size (I vs. C)</cell><cell>Intervention vs. Control Description</cell><cell>Follow-Up</cell></row><row><cell></cell><cell cols="3">Non-Randomized Interventional/Observational Studies</cell><cell></cell></row><row><cell>Bade, 2018 (United States) [35]</cell><cell>Comparative</cell><cell>Advanced-stage (III or IV) lung cancer before, treatment, 15 vs. 29 during or after</cell><cell>Twice-daily personalized text messages regarding activity goals (weekly activity calls to discuss activity goals statements) for 12 wks vs. weekly phone goal, current step count, and motivational</cell><cell>1 mos</cell></row><row><cell>Chow, 2019 (United States) [36]</cell><cell>Single arm observational</cell><cell>Receiving active cancer (chemotherapy), 52 treatment</cell><cell>Text message invitation to complete a for 4 wks (no control group) web-based distress screener one per week</cell><cell>1 mos</cell></row><row><cell>Krok-Schoen, 2019 (United States) [11]</cell><cell>Pre-post</cell><cell>Post-menopausal women with breast cancer (stage 0-III) time, 39 therapy for the first receiving hormone</cell><cell>Daily text message reminders to take hormone therapy medication + weekly mobile app vs. same sample at baseline medication adherence survey within a text message to prompt completion of</cell><cell>3 mos</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Completed daily symptom questionnaires,</cell><cell></cell></row><row><cell>Maguire, 2015 (United [37] Kingdom)</cell><cell>Mixed methods</cell><cell>Lung cancer patients radiotherapy, 16 receiving thoracic</cell><cell>data sent in real time to a central study server and an integrated risk model held by a health professional at the clinic server then generated alerts to a pager analyzed and reported symptoms. The</cell><cell>â¥1 mos</cell></row><row><cell></cell><cell></cell><cell></cell><cell>(no control group)</cell><cell></cell></row><row><cell></cell><cell></cell><cell>HR-positive breast</cell><cell>Interactive daily medication reminders,</cell><cell></cell></row><row><cell>Mougalian,</cell><cell></cell><cell>cancer patients (stage</cell><cell>weekly AE questions, and monthly texts</cell><cell></cell></row><row><cell>2017 (United States)</cell><cell>Pilot</cell><cell>I-III) recommended adjuvant hormonal</cell><cell>regarding barriers to adherence (any alerts generated were forwarded to the</cell><cell>3 mos</cell></row><row><cell>[38]</cell><cell></cell><cell>therapy (follow-up) 100</cell><cell>clinical team) vs. standard care (set of</cell><cell></cell></row><row><cell></cell><cell></cell><cell>vs. 100</cell><cell>historical controls using medical records)</cell><cell></cell></row><row><cell>Rico, 2017 (Brazil) [39]</cell><cell>Single arm Pilot</cell><cell>Outpatients undergoing chemotherapy, 14</cell><cell>Daily text messages promoting self-care control group) and emotional support, sent automatically in conjunction with cHEmotHErApp (no</cell><cell>1 mos</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Interactive text messages on lab testing,</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>adherence to prescribed therapy,</cell><cell></cell></row><row><cell>Sawicki, 2019 (United States) [40]</cell><cell>Retrospective cohort</cell><cell>Patients initiated on TKI therapy (follow-up), 279 vs. 279</cell><cell>symptoms and side effects, and non-interactive medication refill condition-specific management guidance (with links to request a consultation) +</cell><cell>1 yr</cell></row><row><cell></cell><cell></cell><cell></cell><cell>reminders vs. non-interactive medication</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>refill reminders</cell><cell></cell></row><row><cell>Tan, 2019</cell><cell></cell><cell>Cancer patients</cell><cell>Text messaging platform connected to</cell><cell></cell></row><row><cell>(United States)</cell><cell>Retrospective cohort</cell><cell>undergoing radiation</cell><cell>medical records, sent appointment</cell><cell>7 mos</cell></row><row><cell>[41]</cell><cell></cell><cell>therapy, 668 vs. 2761</cell><cell>reminders 2 hours prior vs. no reminders</cell><cell></cell></row><row><cell>Wells, 2020 (United Kingdom) [42]</cell><cell>Mixed methods</cell><cell>Cancer patients receiving treatment and having mild-moderate 30 vs. 21 depressive symptoms, clinical anxiety and/or</cell><cell>MBCT intervention focused on mindfulness skills + text message reminders (reminded patients of home service) intervention (opted out of text messaging upcoming sessions) vs. MBCT practice, info from previous sessions,</cell><cell>1 mos</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_yV9gtPh"><s xml:id="_MrMG7v2">Patient satisfaction (n = 12 studies) and barrier (n = 7 studies) outcomes.</s></p></div></figDesc><table><row><cell>Author, Year</cell><cell>Patient Satisfaction Outcomes a</cell><cell>Barrier Outcomes b</cell></row><row><cell></cell><cell>Randomized Trials</cell><cell></cell></row><row><cell>Gomersall, 2019</cell><cell>Mean satisfaction with text messages was 4.1 SD</cell><cell></cell></row><row><cell>[27]</cell><cell>1.1 (n = 17, scores could range from 1-5)</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table 3 .</head><label>3</label><figDesc><div><p xml:id="_NXYQTfK"><s xml:id="_9tgbSYM">Symptom (n = 6 studies) and quality of life (n = 10 studies) outcomes.</s></p></div></figDesc><table><row><cell>Author, Year</cell><cell>Symptom Outcomes a</cell><cell>QoL Outcomes b</cell></row><row><cell></cell><cell>Randomized Trials</cell><cell></cell></row><row><cell></cell><cell></cell><cell>Mean change score (Week 12-Week 4) for time prolonged</cell></row><row><cell>Gomersall, 2019</cell><cell></cell><cell>sitting (min/16 h awake) in I vs. C: -24.4, 95% CI -47.7,</cell></row><row><cell>[27]</cell><cell></cell><cell>-1.1 (within-group p = 0.04) vs. 0.0, 95% CI -24.8, 24.7</cell></row><row><cell></cell><cell></cell><cell>(within-group p = 1)</cell></row><row><cell>Haggerty, 2017</cell><cell></cell><cell></cell></row><row><cell>[28]</cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_uWkGaFz">Data Availability Statement: Not applicable.</head><p xml:id="_9aP7wwX"><s xml:id="_w7tzzSM">Acknowledgments: Not applicable.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_XcV7Na2">Supplementary Materials:</head><p xml:id="_zhfxVxM"><s xml:id="_M2DZq87">The following are available online at <ref type="url" target="https://www.mdpi.com/article/10.3390/cancers13143542/s1">https://www.mdpi.com/article/10  .3390/cancers13143542/s1</ref>. Figure <ref type="figure">S1</ref>: Bias assessment of the randomized controlled trials (n = 9).</s><s xml:id="_5aeW47T">Figure <ref type="figure">S2</ref>: Bias assessment of the non-randomized interventional/observational studies (n = 9).</s><s xml:id="_6GD8ChX">Table <ref type="table">S1</ref>: Study inclusion and exclusion criteria.</s><s xml:id="_uAd5nyG">Table <ref type="table">S2</ref>: Search strategy for included databases.</s><s xml:id="_r7XKp3C">Table <ref type="table">S3</ref>: Detailed characteristics and outcomes of included studies (n = 18).</s><s xml:id="_TPTJnVA">Table <ref type="table">S4</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2U2U6qH">Conflicts of Interest:</head><p xml:id="_CDB4WAN"><s xml:id="_tcJafKp">The authors declare no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Society</surname></persName>
		</author>
		<author>
			<persName><surname>Supportive Care</surname></persName>
		</author>
		<ptr target="https://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal-childhood/supportive-care/?region=on" />
		<imprint>
			<date type="published" when="2021-05-03">3 May 2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Society, C.C. Supportive Care. Available online: https://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal- childhood/supportive-care/?region=on (accessed on 3 May 2021).</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_sVMpyzj">The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Nipp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>El-Jawahri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Moran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>; D'arpino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Lage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Pirl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Traeger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">T</forename><surname>Lennes</surname></persName>
		</author>
		<idno type="DOI">10.1002/cncr.30912</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SHB9FWh">Cancer</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="4720" to="4727" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nipp, R.D.; El-Jawahri, A.; Moran, S.M.; D&apos;Arpino, S.M.; Johnson, P.C.; Lage, D.E.; Wong, R.L.; Pirl, W.F.; Traeger, L.; Lennes, I.T. The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer. Cancer 2017, 123, 4720-4727. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_zXM6ZGy">Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies</title>
		<author>
			<persName><forename type="first">R</forename><surname>Lentz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Benson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Iii; Kircher</surname></persName>
		</author>
		<idno type="DOI">10.1002/jso.25374</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yVBYh8m">J. Surg. Oncol</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="85" to="92" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lentz, R.; Benson, A.B., III; Kircher, S. Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies. J. Surg. Oncol. 2019, 120, 85-92. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_hCry2bQ">Economic burden of cancer survivorship among adults in the United States</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Guy</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">U</forename><surname>Ekwueme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Yabroff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Dowling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>De Moor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Virgo</surname></persName>
		</author>
		<idno type="DOI">10.1200/jco.2013.49.1241</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GcSsWsV">J. Clin. Oncol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page">3749</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Guy, G.P., Jr.; Ekwueme, D.U.; Yabroff, K.R.; Dowling, E.C.; Li, C.; Rodriguez, J.L.; de Moor, J.S.; Virgo, K.S. Economic burden of cancer survivorship among adults in the United States. J. Clin. Oncol. 2013, 31, 3749. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_TuVgVqw">Cancer Survivors&apos; Experience With Telehealth: A Systematic Review and Thematic Synthesis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Marcu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Piano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Grosvenor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Maguire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ream</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.6575</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8NEvHcz">J. Med. Internet Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1" to="18" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cox, A.; Lucas, G.; Marcu, A.; Piano, M.; Grosvenor, W.; Mold, F.; Maguire, R.; Ream, E. Cancer Survivors&apos; Experience With Telehealth: A Systematic Review and Thematic Synthesis. J. Med. Internet Res. 2017, 19, 1-18. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_gKb2aNP">Older adults and mobile technology: Factors that enhance and inhibit utilization in the context of behavioral health</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kuerbis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mulliken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Muench</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gardner</surname></persName>
		</author>
		<idno type="DOI">10.15761/mhar.1000136</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jEW43FM">Ment. Health Addict. Res</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1" to="11" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kuerbis, A.; Mulliken, A.; Muench, F.; Moore, A.A.; Gardner, D. Older adults and mobile technology: Factors that enhance and inhibit utilization in the context of behavioral health. Ment. Health Addict. Res. 2017, 2, 1-11. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_9Ca2exQ">Mobile telephone text messaging for medication adherence in chronic disease: A meta-analysis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kurup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T.-L</forename><surname>Laba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Santo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thiagalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Woodward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Redfern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chow</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2015.7667</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_k5Rcfpr">JAMA Intern. Med</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="340" to="349" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Thakkar, J.; Kurup, R.; Laba, T.-L.; Santo, K.; Thiagalingam, A.; Rodgers, A.; Woodward, M.; Redfern, J.; Chow, C.K. Mobile telephone text messaging for medication adherence in chronic disease: A meta-analysis. JAMA Intern. Med. 2016, 176, 340-349. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_jz3cwRd">Impact of mHealth chronic disease management on treatment adherence and patient outcomes: A systematic review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hamine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gerth-Guyette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Faulx</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Ginsburg</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.3951</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_T2HmeNs">J. Med. Internet Res</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">52</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hamine, S.; Gerth-Guyette, E.; Faulx, D.; Green, B.B.; Ginsburg, A.S. Impact of mHealth chronic disease management on treatment adherence and patient outcomes: A systematic review. J. Med. Internet Res. 2015, 17, e52. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_3tYMvGC">The impact of mobile health interventions on chronic disease outcomes in developing countries: A systematic review</title>
		<author>
			<persName><forename type="first">A</forename><surname>Beratarrechea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Willner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Jahangir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ciapponi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rubinstein</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2012.0328</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wjHwgbc">Telemed. E Health</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="75" to="82" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Beratarrechea, A.; Lee, A.G.; Willner, J.M.; Jahangir, E.; Ciapponi, A.; Rubinstein, A. The impact of mobile health interventions on chronic disease outcomes in developing countries: A systematic review. Telemed. E Health 2014, 20, 75-82. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_g2DfCKx">Mobile phone text messaging intervention for cervical cancer screening: Changes in knowledge and behavior pre-post intervention</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Koopmeiners</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Rhee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">H</forename><surname>Raveis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Ahluwalia</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.3576</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hJSNwQV">J. Med. Internet Res</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">e196</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee, H.Y.; Koopmeiners, J.S.; Rhee, T.G.; Raveis, V.H.; Ahluwalia, J.S. Mobile phone text messaging intervention for cervical cancer screening: Changes in knowledge and behavior pre-post intervention. J. Med. Internet Res. 2014, 16, e196. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_v3NY4QT">Increasing Adherence to Adjuvant Hormone Therapy Among Patients With Breast Cancer: A Smart Phone App-Based Pilot Study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Krok-Schoen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Naughton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Poi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Melin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Hopkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Paskett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Post</surname></persName>
		</author>
		<idno type="DOI">10.1177/1073274819883287</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9PqGU7Y">Cancer Control</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Krok-Schoen, J.L.; Naughton, M.J.; Young, G.S.; Moon, J.; Poi, M.; Melin, S.A.; Wood, M.E.; Hopkins, J.O.; Paskett, E.D.; Post, D.M. Increasing Adherence to Adjuvant Hormone Therapy Among Patients With Breast Cancer: A Smart Phone App-Based Pilot Study. Cancer Control 2019, 26. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<idno type="DOI">10.26719/2015.21.6.379</idno>
		<title level="m" xml:id="_yJF3GXu">Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on E Health 2009</title>
		<meeting><address><addrLine>Geneva, Switzerland</addrLine></address></meeting>
		<imprint>
			<publisher>World Health Organization</publisher>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization. Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on E Health 2009; World Health Organization: Geneva, Switzerland, 2010.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title level="m" type="main" xml:id="_ym7cBmb">The World Internet Project International Report</title>
		<author>
			<persName><forename type="first">M</forename><surname>Dunahee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lebo</surname></persName>
		</author>
		<idno type="DOI">10.18411/d-2016-154</idno>
		<ptr target="http://www.digitalcenter.org/wp-content/uploads/2013/06/2015-World-Internet-Report.pdf" />
		<imprint>
			<date type="published" when="2016-01-20">2016. 20 January 2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dunahee, M.; Lebo, H. The World Internet Project International Report. 2016. Available online: http://www.digitalcenter.org/ wp-content/uploads/2013/06/2015-World-Internet-Report.pdf (accessed on 20 January 2021).</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_4Xpxbck">SMS for disease control in developing countries: A systematic review of mobile health applications</title>
		<author>
			<persName><forename type="first">C</forename><surname>DÃ©glise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Suggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Odermatt</surname></persName>
		</author>
		<idno type="DOI">10.1258/jtt.2012.110810</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_y7FXn7s">J. Telemed. Telecare</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="273" to="281" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">DÃ©glise, C.; Suggs, L.S.; Odermatt, P. SMS for disease control in developing countries: A systematic review of mobile health applications. J. Telemed. Telecare 2012, 18, 273-281. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_g3CKTWS">Mobile phone messaging for facilitating self-management of long-term illnesses</title>
		<author>
			<persName><forename type="first">T</forename><surname>De Jongh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gurol-Urganci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Vodopivec-Jamsek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Car</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Atun</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.cd007459.pub2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rUNQEbq">Cochrane Database Syst. Rev</title>
		<imprint>
			<biblScope unit="page">12</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">De Jongh, T.; Gurol-Urganci, I.; Vodopivec-Jamsek, V.; Car, J.; Atun, R. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst. Rev. 2012, 12. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_3FEbAGx">Use of telephone and SMS reminders to improve attendance at hospital appointments: A systematic review</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Hasvold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wootton</surname></persName>
		</author>
		<idno type="DOI">10.1258/jtt.2011.110707</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cyAU799">J. Telemed. Telecare</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="358" to="364" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hasvold, P.E.; Wootton, R. Use of telephone and SMS reminders to improve attendance at hospital appointments: A systematic review. J. Telemed. Telecare 2011, 17, 358-364. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_qsFjD5V">Effectiveness of telehealth-based interventions in the management of non-specific low back pain: A systematic review with meta-analysis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Dario</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Cabral</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Almeida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Refshauge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Simic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pappas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Ferreira</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.spinee.2017.04.008</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2N2mh32">Spine J</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1342" to="1351" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dario, A.B.; Cabral, A.M.; Almeida, L.; Ferreira, M.L.; Refshauge, K.; Simic, M.; Pappas, E.; Ferreira, P.H. Effectiveness of telehealth-based interventions in the management of non-specific low back pain: A systematic review with meta-analysis. Spine J. 2017, 17, 1342-1351. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_5gMVpf4">Positive influence of short message service and voice call interventions on adherence and health outcomes in case of chronic disease care: A systematic review</title>
		<author>
			<persName><forename type="first">F</forename><surname>Yasmin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Banu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Zakir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sauerborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Souares</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12911-016-0286-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NYYn8xm">BMC Med. Inform. Decis. Mak</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">46</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yasmin, F.; Banu, B.; Zakir, S.M.; Sauerborn, R.; Ali, L.; Souares, A. Positive influence of short message service and voice call interventions on adherence and health outcomes in case of chronic disease care: A systematic review. BMC Med. Inform. Decis. Mak. 2016, 16, 46. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_wy5Wu74">Using mobile phones and short message service to deliver self-management interventions for chronic conditions: A meta-review</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lekhak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kaewluang</surname></persName>
		</author>
		<idno type="DOI">10.1111/wvn.12030</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_P7TNwsB">Worldviews Evid. Based Nurs</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="81" to="88" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jones, K.R.; Lekhak, N.; Kaewluang, N. Using mobile phones and short message service to deliver self-management interventions for chronic conditions: A meta-review. Worldviews Evid. Based Nurs. 2014, 11, 81-88. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_2QNzT6K">Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement</title>
		<author>
			<persName><forename type="first">D</forename><surname>Moher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Liberati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tetzlaff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Group</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pmed.1000097</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_w2kFyjD">PLoS Med</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">1000097</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; Group, T.P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009, 6, e1000097. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_Mm3yhuj">Quality of Life: The Primary Goal of Lifestyle Intervention</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Daundasekara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Arlinghaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Johnston</surname></persName>
		</author>
		<idno type="DOI">10.1177/1559827620907309</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_53t4ama">Am. J. Lifestyle Med</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="267" to="270" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Daundasekara, S.S.; Arlinghaus, K.R.; Johnston, C.A. Quality of Life: The Primary Goal of Lifestyle Intervention. Am. J. Lifestyle Med. 2020, 14, 267-270. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_YpbSM4F">The role of mobile technologies in health care processes: The case of cancer supportive care</title>
		<author>
			<persName><forename type="first">G</forename><surname>Nasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cucciniello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guerrazzi</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.3757</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eBb35z9">J. Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">26</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nasi, G.; Cucciniello, M.; Guerrazzi, C. The role of mobile technologies in health care processes: The case of cancer supportive care. J. Med Internet Res. 2015, 17, e26. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_TVaACeB">The Cochrane Collaboration&apos;s tool for assessing risk of bias in randomised trials</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>GÃ¸tzsche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>JÃ¼ni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Oxman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>SavoviÄ</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Weeks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Sterne</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.d5928</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MCYftHf">BMJ</title>
		<imprint>
			<biblScope unit="volume">343</biblScope>
			<biblScope unit="page">5928</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Higgins, J.P.; Altman, D.G.; GÃ¸tzsche, P.C.; JÃ¼ni, P.; Moher, D.; Oxman, A.D.; SavoviÄ, J.; Schulz, K.F.; Weeks, L.; Sterne, J.A. The Cochrane Collaboration&apos;s tool for assessing risk of bias in randomised trials. BMJ 2011, 343, d5928. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_xHa2vqy">A tool for assessing risk of bias in non-randomised studies of interventions</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Sterne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>HernÃ¡n</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Reeves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>SavoviÄ</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Berkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Viswanathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Henry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Ansari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Boutron</surname></persName>
		</author>
		<author>
			<persName><surname>Robins-I</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.i4919</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VaK29QM">BMJ</title>
		<imprint>
			<biblScope unit="page">355</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sterne, J.A.; HernÃ¡n, M.A.; Reeves, B.C.; SavoviÄ, J.; Berkman, N.D.; Viswanathan, M.; Henry, D.; Altman, D.G.; Ansari, M.T.; Boutron, I. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016, 355. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_wHvC5jR">The use of mobile technology and peer navigation to promote adolescent and young adult (AYA) cancer survivorship care: Results of a randomized controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Casillas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Crespi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Ganz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Kahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Stuber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bastani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Alquaddomi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Estrin</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11764-019-00777-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_n5VyJbz">J. Cancer Surviv</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="580" to="592" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Casillas, J.N.; Schwartz, L.F.; Crespi, C.M.; Ganz, P.A.; Kahn, K.L.; Stuber, M.L.; Bastani, R.; Alquaddomi, F.; Estrin, D.L. The use of mobile technology and peer navigation to promote adolescent and young adult (AYA) cancer survivorship care: Results of a randomized controlled trial. J. Cancer Surviv. 2019, 13, 580-592. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_fmSZc8z">Feasibility, acceptability and efficacy of a text message-enhanced clinical exercise rehabilitation intervention for increasing &apos;whole-of-day&apos; activity in people living with and beyond cancer</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Gomersall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Skinner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Winkler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Healy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Eakin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fjeldsoe</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12889-019-6767-4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Y3EkyaS">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page">542</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gomersall, S.R.; Skinner, T.L.; Winkler, E.; Healy, G.N.; Eakin, E.; Fjeldsoe, B. Feasibility, acceptability and efficacy of a text message-enhanced clinical exercise rehabilitation intervention for increasing &apos;whole-of-day&apos; activity in people living with and beyond cancer. BMC Public Health 2019, 19, 542. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_9evCFfF">A Randomized, Controlled, Multicenter Study of Technology-Based Weight Loss Interventions among Endometrial Cancer Survivors</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Haggerty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hagemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Barnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Thornquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Neuhouser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Horowitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Colditz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Sarwer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Ko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Allison</surname></persName>
		</author>
		<idno type="DOI">10.1002/oby.22021</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_trNQpDc">Obesity</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="102" to="S108" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Haggerty, A.F.; Hagemann, A.; Barnett, M.; Thornquist, M.; Neuhouser, M.L.; Horowitz, N.; Colditz, G.A.; Sarwer, D.B.; Ko, E.M.; Allison, K.C. A Randomized, Controlled, Multicenter Study of Technology-Based Weight Loss Interventions among Endometrial Cancer Survivors. Obesity 2017, 25, S102-S108. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_P6ufZTZ">Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women with Early-Stage Breast Cancer: SWOG S1105</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Hershman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Unger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Hillyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Moseley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Dakhil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Esparaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Kuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Graham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Lackowski</surname></persName>
		</author>
		<idno type="DOI">10.1200/jco.19.02699</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FE5xafk">J. Clin. Oncol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="2122" to="2129" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hershman, D.L.; Unger, J.M.; Hillyer, G.C.; Moseley, A.; Arnold, K.B.; Dakhil, S.R.; Esparaz, B.T.; Kuan, M.C.; Graham, M.L.; Lackowski, D.M.; et al. Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women with Early-Stage Breast Cancer: SWOG S1105. J. Clin. Oncol. 2020, 38, 2122-2129. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_wsAuDGT">Use of Text Messaging (SMS) for the Management of Side Effects in Cancer Patients Undergoing Chemotherapy Treatment: A Randomized Controlled Trial</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Rico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dos Santos Machado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Fernandes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Madruga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Santin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Petrarca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Dumith</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10916-020-01663-x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8qZZtkR">J. Med. Syst</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1" to="12" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rico, T.M.; dos Santos Machado, K.; Fernandes, V.P.; Madruga, S.W.; Santin, M.M.; Petrarca, C.R.; Dumith, S.C. Use of Text Messaging (SMS) for the Management of Side Effects in Cancer Patients Undergoing Chemotherapy Treatment: A Randomized Controlled Trial. J. Med. Syst. 2020, 44, 1-12. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_76g8p7c">Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: A randomised controlled trial to evaluate the effect of short message service (SMS) reminder</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L A</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E Y</forename><surname>Ang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">Q</forename><surname>Chong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.breast.2020.06.012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UvS2fbv">Breast</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="77" to="84" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tan, E.H.; Wong, A.L.A.; Tan, C.C.; Wong, P.; Tan, S.H.; Ang, L.E.Y.; Lim, S.E.; Chong, W.Q.; Ho, J.; Lee, S.C.; et al. Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: A randomised controlled trial to evaluate the effect of short message service (SMS) reminder. Breast 2020, 53, 77-84. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_YkyvQBq">Telehealth applied to physical activity during cancer treatment: A feasibility, acceptability, and randomized pilot study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Villaron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Eisinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Cappiello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Marqueste</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00520-018-4191-4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BJVGjmy">Support. Care Cancer</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="3413" to="3421" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Villaron, C.; Cury, F.; Eisinger, F.; Cappiello, M.A.; Marqueste, T. Telehealth applied to physical activity during cancer treatment: A feasibility, acceptability, and randomized pilot study. Support. Care Cancer 2018, 26, 3413-3421. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_VJEdnd4">Feasibility of a text messaging intervention to promote self-management for patients prescribed oral anticancer agents</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Spoelstra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Given</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sikorskii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Coursaris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Majumder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dekoekkoek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Given</surname></persName>
		</author>
		<idno type="DOI">10.1188/15.onf.647-657</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rEJkFJc">Oncol. Nurs. Forum</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="647" to="657" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Spoelstra, S.L.; Given, C.W.; Sikorskii, A.; Coursaris, C.K.; Majumder, A.; DeKoekkoek, T.; Schueller, M.; Given, B.A. Feasibility of a text messaging intervention to promote self-management for patients prescribed oral anticancer agents. Oncol. Nurs. Forum 2015, 42, 647-657. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_hKB9yZV">Proof of concept of a mobile health short message service text message intervention that promotes adherence to oral anticancer agent medications: A randomized controlled trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Spoelstra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Given</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sikorskii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Coursaris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Majumder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dekoekkoek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Given</surname></persName>
		</author>
		<idno type="DOI">10.1089/tmj.2015.0126</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QkgwRMF">Telemed. E Health</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="497" to="506" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Spoelstra, S.L.; Given, C.W.; Sikorskii, A.; Coursaris, C.K.; Majumder, A.; DeKoekkoek, T.; Schueller, M.; Given, B.A. Proof of concept of a mobile health short message service text message intervention that promotes adherence to oral anticancer agent medications: A randomized controlled trial. Telemed. E Health 2016, 22, 497-506. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_wD9GPPk">A Patient-Centered Activity Regimen Improves Participation in Physical Activity Interventions in Advanced-Stage Lung Cancer</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Bade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Hyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Bevill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pastis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Rojewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Toll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Silvestri</surname></persName>
		</author>
		<idno type="DOI">10.1177/1534735418781739</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RXdCzWH">Integr. Cancer Ther</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="921" to="927" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bade, B.C.; Hyer, J.M.; Bevill, B.T.; Pastis, A.; Rojewski, A.M.; Toll, B.A.; Silvestri, G.A. A Patient-Centered Activity Regimen Improves Participation in Physical Activity Interventions in Advanced-Stage Lung Cancer. Integr. Cancer Ther. 2018, 17, 921-927. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_Ncqsy9Z">Examining the feasibility, acceptability, and potential utility of mobile distress screening in adult cancer patients</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">I</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Drago</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chambers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sheffield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Cohn</surname></persName>
		</author>
		<idno type="DOI">10.1002/pon.5168</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6shW948">Psycho Oncol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1887" to="1893" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chow, P.I.; Drago, F.; Kennedy, E.M.; Chambers, N.; Sheffield, C.; Cohn, W.F. Examining the feasibility, acceptability, and potential utility of mobile distress screening in adult cancer patients. Psycho Oncol. 2019, 28, 1887-1893. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_tKVQYK3">Development of a novel remote patient monitoring system: The advanced symptom management system for radiotherapy to improve the symptom experience of patients with lung cancer receiving radiotherapy</title>
		<author>
			<persName><forename type="first">R</forename><surname>Maguire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ream</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Richardson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Connaghan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kotronoulas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pedersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcphelim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Pattison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1097/ncc.0000000000000150</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VZ4qvmR">Cancer Nurs</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="37" to="E47" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maguire, R.; Ream, E.; Richardson, A.; Connaghan, J.; Johnston, B.; Kotronoulas, G.; Pedersen, V.; McPhelim, J.; Pattison, N.; Smith, A.; et al. Development of a novel remote patient monitoring system: The advanced symptom management system for radiotherapy to improve the symptom experience of patients with lung cancer receiving radiotherapy. Cancer Nurs. 2015, 1, E37-E47. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_K7rZ8np">Bidirectional text messaging to monitor endocrine therapy adherence and patient-reported outcomes in breast Cancer</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Mougalian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Epstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Jhaveri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Abu-Khalaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Hofstatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Digiovanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Silber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Adelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pusztai</surname></persName>
		</author>
		<idno type="DOI">10.1200/cci.17.00015</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_b9c6j29">JCO Clin. Cancer Inform</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mougalian, S.S.; Epstein, L.N.; Jhaveri, A.P.; Han, G.; Abu-Khalaf, M.; Hofstatter, E.W.; DiGiovanna, M.P.; Silber, A.L.; Adelson, K.; Pusztai, L. Bidirectional text messaging to monitor endocrine therapy adherence and patient-reported outcomes in breast Cancer. JCO Clin. Cancer Inform. 2017, 1, 1-10. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_nX2fdjd">Text Messaging (SMS) Helping Cancer Care in Patients Undergoing Chemotherapy Treatment: A Pilot Study</title>
		<author>
			<persName><forename type="first">T</forename><surname>Rico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Santos Machado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fernandes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Madruga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Noguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Barcelos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Santin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Petrarca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dumith</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10916-017-0831-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PRqpBmp">J. Med. Syst</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rico, T.; Santos Machado, K.; Fernandes, V.; Madruga, S.; Noguez, P.c.; Barcelos, C.; Santin, M.; Petrarca, C.; Dumith, S. Text Messaging (SMS) Helping Cancer Care in Patients Undergoing Chemotherapy Treatment: A Pilot Study. J. Med. Syst. 2017, 41, 1-8. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_pxvwZbX">Two-Way Clinical Messaging in a CML Specialty Pharmacy Service Model</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sawicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Friend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Polinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Singh</surname></persName>
		</author>
		<idno type="DOI">10.18553/jmcp.2019.25.11.1290</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SxJWNgW">J. Manag. Care Spec. Pharm</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1290" to="1296" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sawicki, C.; Friend, K.E.; Patel, R.; Polinski, J.M.; Singh, S. Two-Way Clinical Messaging in a CML Specialty Pharmacy Service Model. J. Manag. Care Spec. Pharm. 2019, 25, 1290-1296. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_wxgr6Hx">Automated text message reminders improve radiation therapy compliance</title>
		<author>
			<persName><forename type="first">J</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Christie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Montalvo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Folkerts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yingling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Choy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijrobp.2018.11.050</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_acFHWjQ">Int. J. Radiat. Oncol. Biol. Phys</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="1045" to="1052" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tan, J.; Christie, A.; Montalvo, S.K.; Wallace, C.; Yan, Y.; Folkerts, M.; Yingling, A.; Sher, D.; Choy, H.; Jiang, S. Automated text message reminders improve radiation therapy compliance. Int. J. Radiat. Oncol. Biol. Phys. 2019, 103, 1045-1052. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_UzQzmnM">Using smart-messaging to enhance mindfulness-based cognitive therapy for cancer patients: A mixed methods proof of concept evaluation</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wells</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Malins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Skorodzien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Biswas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sweeney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Moghaddam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Levene</surname></persName>
		</author>
		<idno type="DOI">10.1002/pon.5256</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aAv7vXM">Psycho Oncol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="212" to="219" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wells, C.; Malins, S.; Clarke, S.; Skorodzien, I.; Biswas, S.; Sweeney, T.; Moghaddam, N.; Levene, J. Using smart-messaging to enhance mindfulness-based cognitive therapy for cancer patients: A mixed methods proof of concept evaluation. Psycho Oncol. 2020, 29, 212-219. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_vgsDC5T">Healthcare in the pocket: Mapping the space of mobile-phone health interventions</title>
		<author>
			<persName><forename type="first">P</forename><surname>Klasnja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Pratt</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jbi.2011.08.017</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YPyZufD">J. Biomed. Inform</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="184" to="198" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Klasnja, P.; Pratt, W. Healthcare in the pocket: Mapping the space of mobile-phone health interventions. J. Biomed. Inform. 2012, 45, 184-198. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_xhxEcfG">Mobile text messaging for health: A systematic review of reviews</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cole-Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Bernhardt</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev-publhealth-031914-122855</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Y2sZH48">Annu. Rev. Public Health</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="393" to="415" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hall, A.K.; Cole-Lewis, H.; Bernhardt, J.M. Mobile text messaging for health: A systematic review of reviews. Annu. Rev. Public Health 2015, 36, 393-415. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_rFfcY7g">Self-management education: History, definition, outcomes, and mechanisms</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Lorig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Holman</surname></persName>
		</author>
		<idno type="DOI">10.1207/S15324796ABM2601_01</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rfxBW3A">Ann. Behav. Med</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lorig, K.R.; Holman, H.R. Self-management education: History, definition, outcomes, and mechanisms. Ann. Behav. Med. 2003, 26, 1-7. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_NRqbE6Z">Telehealth and patient satisfaction: A systematic review and narrative analysis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Kruse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Krowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brooks</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2017-016242</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hwfAB48">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">16242</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kruse, C.S.; Krowski, N.; Rodriguez, B.; Tran, L.; Vela, J.; Brooks, M. Telehealth and patient satisfaction: A systematic review and narrative analysis. BMJ Open 2017, 7, e016242. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_GpP9Ava">Economic Evaluation of Text-Messaging and Smartphone-Based Interventions to Improve Medication Adherence in Adolescents with Chronic Health Conditions: A Systematic Review</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Badawy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Kuhns</surname></persName>
		</author>
		<idno type="DOI">10.2196/mhealth.6425</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HNemGRp">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">121</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Badawy, S.M.; Kuhns, L.M. Economic Evaluation of Text-Messaging and Smartphone-Based Interventions to Improve Medication Adherence in Adolescents with Chronic Health Conditions: A Systematic Review. JMIR Mhealth Uhealth 2016, 4, e121. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_we4M46M">The RE-AIM framework: A systematic review of use over time</title>
		<author>
			<persName><forename type="first">B</forename><surname>Gaglio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Shoup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Glasgow</surname></persName>
		</author>
		<idno type="DOI">10.2105/ajph.2013.301299</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_D3SMxE9">Am. J. Public Health</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="38" to="e46" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gaglio, B.; Shoup, J.A.; Glasgow, R.E. The RE-AIM framework: A systematic review of use over time. Am. J. Public Health 2013, 103, e38-e46. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_xusjZYt">Effectiveness-implementation hybrid designs: Combining elements of clinical effectiveness and implementation research to enhance public health impact</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Curran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mittman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Pyne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stetler</surname></persName>
		</author>
		<idno type="DOI">10.1097/MLR.0b013e3182408812</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_x8Ts6uu">Med Care</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page">217</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Curran, G.M.; Bauer, M.; Mittman, B.; Pyne, J.M.; Stetler, C. Effectiveness-implementation hybrid designs: Combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care 2012, 50, 217. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_kCUtx6q">An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Wells</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Del Paggio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Hopman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gyawali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mukherji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hammad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pramesh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Aggarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sullivan</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamaoncol.2020.7478</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_G9rTmyE">JAMA Oncol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="379" to="385" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wells, J.C.; Sharma, S.; Del Paggio, J.C.; Hopman, W.M.; Gyawali, B.; Mukherji, D.; Hammad, N.; Pramesh, C.; Aggarwal, A.; Sullivan, R. An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries. JAMA Oncol. 2021, 7, 379-385. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_DMQCKcb">Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: A population-based study</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jacob</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Yap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ferlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Barton</surname></persName>
		</author>
		<idno type="DOI">10.1016/S1470-2045(19)30163-9</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wtKQynA">Lancet Oncol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="769" to="780" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wilson, B.E.; Jacob, S.; Yap, M.L.; Ferlay, J.; Bray, F.; Barton, M.B. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: A population-based study. Lancet Oncol. 2019, 20, 769-780. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_k54ZqfC">GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</title>
		<author>
			<persName><forename type="first">H</forename><surname>Sung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ferlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Laversanne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Soerjomataram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jemal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bray</surname></persName>
		</author>
		<idno type="DOI">10.3322/caac.21660</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eRcGWNZ">CA Cancer J. Clin</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="209" to="249" />
			<date type="published" when="2020">2020. 2021</date>
		</imprint>
	</monogr>
	<note>Global cancer statistics</note>
	<note type="raw_reference">Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021, 71, 209-249. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b51">
	<monogr>
		<title level="m" xml:id="_hUadcxe">World Development Report 2016: Digital Dividends</title>
		<meeting><address><addrLine>Washington, DC, USA</addrLine></address></meeting>
		<imprint>
			<publisher>World Bank Publications</publisher>
			<date type="published" when="2016">2016</date>
			<biblScope unit="page" from="5" to="9" />
		</imprint>
	</monogr>
	<note type="raw_reference">WorldBank. World Development Report 2016: Digital Dividends; World Bank Publications: Washington, DC, USA, 2016; pp. 5-9.</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_bDK25xk">Providing Supportive and Palliative Care Using Telemedicine for Patients with Advanced Cancer During the COVID-19 Pandemic in Mexico</title>
		<author>
			<persName><forename type="first">Y</forename><surname>ChÃ¡varri-Guerra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Ramos-LÃ³pez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Covarrubias-GÃ³mez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>SÃ¡nchez-RomÃ¡n</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Quiroz-Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Alcocer-Castillejos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pilar</forename><surname>Del</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Milke-GarcÃ­a</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Carrillo-Soto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Morales-Alfaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Medina-Palma</surname></persName>
		</author>
		<idno type="DOI">10.1002/onco.13568</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Ahzk5NG">Oncologist</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="512" to="e515" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">ChÃ¡varri-Guerra, Y.; Ramos-LÃ³pez, W.A.; Covarrubias-GÃ³mez, A.; SÃ¡nchez-RomÃ¡n, S.; Quiroz-Friedman, P.; Alcocer-Castillejos, N.; del Pilar Milke-GarcÃ­a, M.; Carrillo-Soto, M.; Morales-Alfaro, A.; Medina-Palma, M. Providing Supportive and Palliative Care Using Telemedicine for Patients with Advanced Cancer During the COVID-19 Pandemic in Mexico. Oncologist 2021, 26, e512-e515. [CrossRef</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
